<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:47:29Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3574195" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3574195</identifier><datestamp>2013-02-19</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell</journal-id>
      <journal-title-group>
        <journal-title>Cell</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0092-8674</issn>
      <issn pub-type="epub">1097-4172</issn>
      <publisher>
        <publisher-name>Cell Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3574195</article-id>
      <article-id pub-id-type="pmcid">PMC3574195</article-id>
      <article-id pub-id-type="pmc-uid">3574195</article-id>
      <article-id pub-id-type="pmid">23374346</article-id>
      <article-id pub-id-type="publisher-id">S0092-8674(13)00019-6</article-id>
      <article-id pub-id-type="doi">10.1016/j.cell.2013.01.013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Ubiad1 Is an Antioxidant Enzyme that Regulates eNOS Activity by CoQ10 Synthesis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mugoni</surname>
            <given-names>Vera</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Postel</surname>
            <given-names>Ruben</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Catanzaro</surname>
            <given-names>Valeria</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DeÂ Luca</surname>
            <given-names>Elisa</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Turco</surname>
            <given-names>Emilia</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Digilio</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Silengo</surname>
            <given-names>Lorenzo</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Murphy</surname>
            <given-names>MichaelÂ P.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Medana</surname>
            <given-names>Claudio</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stainier</surname>
            <given-names>DidierÂ Y.R.</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bakkers</surname>
            <given-names>Jeroen</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santoro</surname>
            <given-names>MassimoÂ M.</given-names>
          </name>
          <email>massimo.santoro@unito.it</email>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy</aff>
      <aff id="aff2"><label>2</label>Department of Chemistry, University of Torino, 10126 Torino, Italy</aff>
      <aff id="aff3"><label>3</label>Hubrecht Institute-KNAW and University Medical Center Utrecht and Netherlands Heart Institute, 3584 CT Utrecht, The Netherlands</aff>
      <aff id="aff4"><label>4</label>Medical Research Council Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK</aff>
      <aff id="aff5"><label>5</label>Department of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany</aff>
      <author-notes>
        <corresp id="cor1"><label>â</label>Corresponding author <email>massimo.santoro@unito.it</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>31</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <day>31</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <volume>152</volume>
      <issue>3</issue>
      <fpage>504</fpage>
      <lpage>518</lpage>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>2</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2013 ELL &amp; Excerpta Medica.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license xlink:href="https://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>Open Access under <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/3.0/">CC BY-NC-ND 3.0</ext-link> license</license-p>
        </license>
      </permissions>
      <abstract>
        <title>Summary</title>
        <p>Protection against oxidative damage caused by excessive reactive oxygen species (ROS) by an antioxidant network is essential for the health of tissues, especially in the cardiovascular system. Here, we identified a gene with important antioxidant features by analyzing a null allele of zebrafish <italic>ubiad1</italic>, called <italic>barolo</italic> (<italic>bar</italic>). <italic>bar</italic> mutants show specific cardiovascular failure due to oxidative stress and ROS-mediated cellular damage. Human UBIAD1 is a nonmitochondrial prenyltransferase that synthesizes CoQ10 in the Golgi membrane compartment. Loss of UBIAD1 reduces the cytosolic pool of the antioxidant CoQ10 and leads to ROS-mediated lipid peroxidation in vascular cells. Surprisingly, inhibition of eNOS prevents Ubiad1-dependent cardiovascular oxidative damage, suggesting a crucial role for thisÂ enzyme and nonmitochondrial CoQ10 in NO signaling. These findings identify UBIAD1 as a nonmitochondrial CoQ10-forming enzyme with specific cardiovascular protective function via the modulation of eNOS activity.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <sec>
          <title>Graphical Abstract</title>
          <p>
            <fig id="undfig1" position="anchor">
              <graphic xlink:href="fx1"/>
            </fig>
          </p>
        </sec>
        <sec>
          <title>Highlights</title>
          <p>âº UBIAD1 is a Golgi prenyltransferase âº UBIAD1 contributes to the nonmitochondrial pool of CoQ10 âº UBIAD1 protects cardiovascular tissues from NOS-dependent oxidative damage âº UBIAD1 is a target for therapeutic strategies by limiting the side effects of statins</p>
        </sec>
      </abstract>
      <abstract abstract-type="teaser">
        <p>UBIAD1 is identified as a nonmitochondrial CoQ10 biosynthetic enzyme required for oxidative damage protection. Through CoQ10 synthesis, UBIAD1 modulates endothelial nitric oxide synthase activity and nitric oxide signaling necessary for cardiovascular development and homeostasis.</p>
      </abstract>
    </article-meta>
    <notes>
      <p>Published: January 31, 2013</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec1">
      <title>Introduction</title>
      <p>Reactive oxygen species (ROS) play an important role in signal transduction and physiological regulation of the cardiovascular system by facilitating various biological responses, including senescence in heart and endothelial cells (ECs) (<xref rid="bib30" ref-type="bibr">Lander etÂ al., 1996</xref>; <xref rid="bib13" ref-type="bibr">Finkel, 2003</xref>; <xref rid="bib14" ref-type="bibr">Finkel and Holbrook, 2000</xref>; <xref rid="bib21" ref-type="bibr">Hare and Stamler, 2005</xref>; <xref rid="bib11" ref-type="bibr">DâAutrÃ©aux and Toledano, 2007</xref>). In cardiovascular tissues, ROS are normally produced in response to RTK and GPC receptor signaling, as well as during mechanical (shear) stress. ROS help regulate cardiovascular homeostasis (<xref rid="bib7" ref-type="bibr">Colavitti etÂ al., 2002</xref>; <xref rid="bib63" ref-type="bibr">Werner, 2004</xref>; <xref rid="bib60" ref-type="bibr">Ushio-Fukai, 2006</xref>). An antioxidant network is required to balance these ROS and prevent oxidative damage, which may contribute to cardiovascular pathologies (<xref rid="bib13" ref-type="bibr">Finkel, 2003</xref>; <xref rid="bib20" ref-type="bibr">Giordano, 2005</xref>; <xref rid="bib29" ref-type="bibr">Kuster etÂ al., 2010</xref>). Although several enzymes responsible for ROS production in ECs have been identified, many of the molecules involved in the endogenous antioxidant network are unknown.</p>
      <p>A molecule known to play an important antioxidant role in the cardiovascular system is CoQ10 (also known as Coenzyme Q10 or ubiquinone) (<xref rid="bib45" ref-type="bibr">Pepe etÂ al., 2007</xref>; <xref rid="bib28" ref-type="bibr">Kumar etÂ al., 2009</xref>). CoQ10 isÂ the only endogenously synthesized lipid-soluble antioxidant (<xref rid="bib9" ref-type="bibr">Crane, 2007</xref>; <xref rid="bib2" ref-type="bibr">Bentinger etÂ al., 2007</xref>). It is available in the membranes of the Golgi, where it is present at an even higher concentration than in the mitochondria, as well as in plasma membranes (<xref rid="bib26" ref-type="bibr">Kalen etÂ al., 1987</xref>; <xref rid="bib8" ref-type="bibr">Crane, 2001</xref>; <xref rid="bib3" ref-type="bibr">Bentinger etÂ al., 2008</xref>). Although the biosynthesis of CoQ10 in mitochondria has been studied inÂ detail, only a limited amount of data is available in regards toÂ the synthesis of cellular membrane CoQ10. Several inÂ vivo experiments suggest that CoQ10 synthesis may also occur in the Golgi and endoplasmic reticulum membranes, providing the cellular membrane CoQ10 pool (<xref rid="bib27" ref-type="bibr">KalÃ©n etÂ al., 1990</xref>). However, although hypothesized, a ânonmitochondrialâ CoQ10 biosynthetic enzyme has not been identified (<xref rid="bib4" ref-type="bibr">Bentinger etÂ al., 2010</xref>). Identification of such an enzyme could be extremely useful in order to devise strategies to counteract the excess of ROS responsible for cellular oxidative damage (such as lipid peroxidation, protein nitrosylation, and DNA oxidation) and therefore balance redox signaling especially in cardiovascular tissues.</p>
      <p>CoQ10 is a mobile lipophilic electron carrier that is critical forÂ electron transfer both in the mitochondrial membrane for respiratory chain activity as well as in Golgi and plasma membranes for NAD(P)H-oxidoreductase-dependent reactions such as in NO synthesis (<xref rid="bib38" ref-type="bibr">Navas etÂ al., 2007</xref>). Endothelial nitric oxide synthase (eNOS) is a critical regulator of cardiovascular functions by generating nitric oxide (NO), which is an important mediator of cardiovascular homeostasis (<xref rid="bib1" ref-type="bibr">Alp and Channon, 2004</xref>; <xref rid="bib16" ref-type="bibr">FÃ¶rstermann and Sessa, 2012</xref>). As in the case with nonmitochondrial CoQ10, eNOS is specifically localized in the Golgi and plasma membrane of heart and endothelial cells, and it can be differentially regulated in these two cellular compartments (<xref rid="bib19" ref-type="bibr">Fulton etÂ al., 2002</xref>). Different reports have suggested that CoQ10 may improve endothelial dysfunction by ârecouplingâ eNOS and modulating NO-related signaling (<xref rid="bib6" ref-type="bibr">Chew and Watts, 2004</xref>; <xref rid="bib58" ref-type="bibr">Tsai etÂ al., 2012</xref>).</p>
      <p>Here, we identify UBIAD1 as an enzyme for CoQ10 synthesis atÂ the level of Golgi membranes and show that it is critical for oxidative stress protection. In particular, UBIAD1 protects cardiovascular tissues from eNOS-dependent oxidative stress. We propose a functional link between UBIAD1, CoQ10, and NO signaling during cardiovascular development and homeostasis.</p>
    </sec>
    <sec sec-type="results" id="sec2">
      <title>Results</title>
      <sec id="sec2.1">
        <title>Oxidative Stress and Cardiovascular Failure Characterize <italic>barolo</italic> Mutants</title>
        <p>By forward genetic screens for cardiovascular mutants (2005 Tuebingen screen; <xref rid="bib24" ref-type="bibr">Jin etÂ al., 2007</xref>), we identified mutations in the <italic>barolo</italic> (<italic>bar</italic>) gene (<italic>bar</italic><sup>t31131</sup> and <italic>bar</italic><sup>s847</sup>). These mutations are recessive and show complete penetrance and expressivity. <italic>bar</italic> mutants show distinct cranial vascular hemorrhages and pericardial edema in the context of wild-type body morphology (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>A). To examine whether this phenotype is associated with cardiovascular defects, we crossed the mutations into <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>B). The hemorrhagic phenotype in <italic>bar</italic> mutants is accompanied by endothelial regression and fragmentation in the cranial and trunk vascular compartments (<xref rid="fig1" ref-type="fig">Figures 1</xref>C and 1D). Time-lapse analyses of trunk vasculature indicate that the <italic>bar</italic> phenotype starts around 36Â hr postfertilization (hpf) (<xref rid="mmc2" ref-type="supplementary-material">Movies S1</xref>, <xref rid="mmc3" ref-type="supplementary-material">S2</xref>, <xref rid="mmc4" ref-type="supplementary-material">S3</xref>, and <xref rid="mmc5" ref-type="supplementary-material">S4</xref>) and that it is not due to general loss of blood flow. The cardiac edema of <italic>bar</italic> mutants is caused by a gradual breakdown of endocardial and myocardial cells in the heart, leading to the collapse of the heart between 60 and 72 hpf (data not shown). All these features lead to the complete cardiac and vascular organ failure by 72 hpf in <italic>bar</italic> mutant embryos.</p>
        <p>Cardiovascular failure is related to altered redox signaling and an increased production of ROS (<xref rid="bib21" ref-type="bibr">Hare and Stamler, 2005</xref>). <italic>bar</italic> mutants compared to wild-type siblings show altered redox balance and oxidative stress features evaluated as an increase of the NADP/NADPH ratio and as an overexpression of antioxidant genes, respectively (<xref rid="fig1" ref-type="fig">Figures 1</xref>E and 1F). Increase of ROS production occurs specifically in cardiovascular tissues as demonstrated by measuring oxidizing species in ECs of <italic>bar</italic> mutants using the selective and stable ROS detector CellROX (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>G). We also measured S-nitrosylation levels on heart and blood vessel sections of <italic>bar</italic> mutants. <italic>bar</italic> mutants show higher levels of S-nitrosylated proteins in heart and blood vessel cells as well as in pronephros as measured by an antibody against S-nitroso-cysteine (SNO-Cys) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>H). A high level of S-nitrosylated proteins is normally associated with altered redox signaling and cellular protection against oxidative stress (<xref rid="bib53" ref-type="bibr">Stamler etÂ al., 2001</xref>; <xref rid="bib23" ref-type="bibr">Hess etÂ al., 2005</xref>; <xref rid="bib55" ref-type="bibr">Sun and Murphy, 2010</xref>).</p>
        <p>We found that cardiovascular tissues from <italic>bar</italic> mutants areÂ positive for 8-hydroxy-2â²-deoxyguanosine (8-OHdG), a free radical-induced oxidative lesion in DNA (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>I). Analyses of heart and blood vessel sections show that both myocardial and endothelial tissues of <italic>bar</italic> mutants exhibit ROS-mediated DNA damage compared to controls. Indeed, endothelial and endocardial cells in <italic>bar</italic> mutants were positive for TUNEL staining and show typical morphological features of apoptotic cells at this stage (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>L). In summary, both mutant embryos carrying the <italic>barolo</italic> mutation show increased oxidative stress, DNA damage, and cell death specifically in blood vessels and the heart.</p>
        <p>We determined that <italic>bar</italic> encodes Ubiad1 (<italic>UbiA</italic>-<italic>d</italic>omain containing protein <italic>1</italic>) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>M). Sequence analyses show that the <italic>bar</italic><sup>t31131</sup> mutant allele contains a nonsense mutation (123Â TÂ &gt; A) in <italic>ubiad1</italic> introducing a premature stop codon at amino acid position 41, likely generating a null allele. The second allele of <italic>bar</italic> (<italic>bar</italic><sup>s847</sup>) bears a base change (185Â T &gt; A) leading to the substitution of a conserved leucine residue to glutamine at amino acid position 62 (Ubiad1<sup>L62Q</sup>) (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>N). <italic>bar</italic><sup>s847</sup> shows the same phenotypical features as <italic>bar</italic><sup>t31131</sup> except the phenotype is delayed by 12Â hr (<xref rid="figs1" ref-type="fig">Figures S1</xref>AâS1E and S1T available online). Both <italic>bar</italic> allele mutants do not express Ubiad1 (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>O) and are fully rescued by Ubiad1 mRNA expression. Ubiad1<sup>L62Q</sup> mRNA does not rescue the <italic>bar</italic><sup>t31131</sup> mutant indicating that this amino acid mutation is sufficient to knock out Ubiad1 activity (<xref rid="fig1" ref-type="fig">FigureÂ 1</xref>P). To confirm that Ubiad1 regulates cardiovascular protection and survival, we knocked down Ubiad1 expression using an antisense morpholino oligonucleotide. <italic>Ubiad1</italic> morphants show the same hemorrhagic phenotype and cardiovascular defects as <italic>bar</italic> mutants (<xref rid="figs1" ref-type="fig">Figures S1</xref>FâS1I).</p>
        <p>Analyses of <italic>ubiad1</italic> mRNA expression in developing zebrafish embryos reveal a ubiquitous expression at 24 hpf in addition toÂ aÂ distinct expression in the heart at 48 hpf (<xref rid="figs1" ref-type="fig">Figures S1</xref>JâS1L), in agreement with mammalian expression data (<xref rid="bib37" ref-type="bibr">Nakagawa etÂ al., 2010</xref>). In addition, cell transplantation and tissue-specific rescue experiments showed that Ubiad1 functions autonomously within endothelial and endocardial cells (<xref rid="figs1" ref-type="fig">Figures S1</xref>MâS1P and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>).</p>
        <p>These data indicate that loss of <italic>ubiad1</italic> triggers a progressive cardiovascular failure by increasing oxidative stress and apoptosis in heart and blood vessels suggesting a role for Ubiad1 as a controller of redox state and ROS levels in vertebrate cardiovascular tissues (<xref rid="figs1" ref-type="fig">FigureÂ S1</xref>Q). Thereby, <italic>bar</italic> represents a unique model to study oxidative stress conditions and redox signaling during zebrafish development.</p>
      </sec>
      <sec id="sec2.2">
        <title>UBIAD1 Is a CoQ10 Biosynthetic Enzyme</title>
        <p>Ubiad1 is conserved among species and contains an UbiA prenyltransferase domain, present also in the vertebrate protein Coq2. So far, the mitochondrial enzyme Coq2 is the only vertebrate enzyme known to synthesize CoQ10 through the prenylation of 4-hydroxybenzoic acid by oligoprenyl diphosphates (<xref rid="bib15" ref-type="bibr">Forsgren etÂ al., 2004</xref>). The CoQ10 molecule is composed of a redox active benzoquinone ring, which is connected to a polyisoprenoid side chain of variable length (typically 9/10 units in vertebrates) (<xref rid="bib8" ref-type="bibr">Crane, 2001</xref>). As with Coq2, we speculate that Ubiad1 might catalyze the biosynthesis of CoQ10. We measured CoQ10 levels in <italic>bar</italic> mutants and <italic>ubiad1</italic> morphants by HPLC-MS (<xref rid="fig2" ref-type="fig">Figures 2</xref>A and 2B). The absence of Ubiad1 in zebrafish larvae significantly reduces CoQ10 levels (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>C), whereas cholesterol levels are not significantly affected (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>A). By the time course of synthesis analyses, we found that CoQ10 increases during zebrafish embryonic development and is almost entirely produced by the zygote without any contribution from the yolk sac (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>B). On the other hand, a significant amount of embryonic cholesterol is provided by the yolk sac throughout early development (<xref rid="figs2" ref-type="fig">FigureÂ S2</xref>C). These data suggest that de novo zygotic synthesis of CoQ10 by Ubiad1 (and/or Coq2) is required for zebrafish development.</p>
        <p>To test whether it is the absence of CoQ10 synthesis in zebrafish embryos that causes the <italic>bar</italic> phenotype, we injected CoQ10 in single-cell stage <italic>bar</italic> mutants (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>D). Three different CoQ10 formulations rescue <italic>bar</italic> mutants, suggesting that the intake of CoQ10 in Ubiad1 deficient embryos may restore normalÂ cardiovascular development. A recent paper reports that UBIAD1 is required for Vitamin K2 production (<xref rid="bib37" ref-type="bibr">Nakagawa etÂ al., 2010</xref>); however, our data indicate that a lack of Vitamin K2 is not responsible for the cardiovascular phenotype in <italic>bar</italic> mutants (<xref rid="fig2" ref-type="fig">Figures 2</xref>D and <xref rid="figs2" ref-type="fig">S2</xref>DâS2K).</p>
        <p>To provide biochemical evidence that Ubiad1 is able to synthesize CoQ10, we performed metabolic studies in zebrafish embryos by analyzing the ability of <italic>bar</italic> mutants to convert hydroxy-4-benzoic acid to CoQ10 (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E). We confirmed that administration of <sup>13</sup>C<sub>6</sub>-labeled hydroxy-4-benzoic acid (hydroxy-4-benzoic acid-<sup>13</sup>C<sub>6</sub>) is metabolized to CoQ10-<sup>13</sup>C<sub>6</sub> in zebrafish embryos by injecting this C<sup>13</sup>-labeled precursor in zebrafish embryos at one-cell stage. After 72 hpf of incubation, lipids were extracted and analyzed by HPLC-MS to quantify the amount of CoQ10-<sup>13</sup>C<sub>6</sub> formed (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>E). <italic>bar</italic> mutants show a reduced CoQ10-<sup>13</sup>C<sub>6</sub> production compared to wild-type siblings. CoQ9-<sup>13</sup>C<sub>6</sub> production was also impaired (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>F), indicating that zebrafish larvae can synthesize both CoQ9 and CoQ10 as can human cells (<xref rid="bib59" ref-type="bibr">Turunen etÂ al., 2004</xref>). Therefore, Ubiad1 is a 4-OH-benzoic acid-prenyl-tranferase enzyme required for CoQ10 and CoQ9 biosynthesis inÂ vivo.</p>
        <p>Ubiad1 and HMG-CoA Reductase inhibitors act in the Mevalonate Pathway for CoQ10-Dependent Cardiovascular Oxidative Stress Protection.</p>
        <p>The rate-limiting reaction in the biosynthesis of CoQ10 is theÂ transfer of the polyprenyl-pyrophosphate (polyprenyl-PP) chain, derived from mevalonate, on to 4-OH-benzoic acid, derived from tyrosine metabolism (<xref rid="bib3" ref-type="bibr">Bentinger etÂ al., 2008</xref>) (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). We reduced the pool of polyprenyl-PP available for CoQ10 synthesis by treating zebrafish embryos with statins, inhibitors of its precursor (e.g., mevalonate) (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>A). By blocking HMG-CoA reductase, statins impair the mevalonate and FPP synthesis, which is mandatory to synthetize the polyprenyl-PP chain (<xref rid="fig2" ref-type="fig">FigureÂ 2</xref>A). Wild-type embryos (<italic>ubiad1</italic><sup><italic>+/+</italic></sup>) treated with statin developed a <italic>bar</italic>-like phenotype (<xref rid="fig3" ref-type="fig">Figures 3</xref>Aâ3C). Statin treatments efficiently reduced CoQ10 synthesis without interfering with cholesterol levels, probably because statin treatment blocks de novo cholesterol biosynthesis but does not interfere with the maternally provided cholesterol (<xref rid="fig3" ref-type="fig">Figures 3</xref>D and 3E). Zebrafish embryos treated with the squalene synthase inhibitor (SQI) or with farnesyl or geranyl-geranyl tranferase inhibitors (FTI or GGTI) did not exhibit a <italic>bar</italic>-like phenotype (<xref rid="figs3" ref-type="fig">FigureÂ S3</xref>B), indicating that the absence of CoQ10 is the cause of the statin-induced cardiovascular oxidative phenotype. Furthermore, while treatment withÂ a low-doseÂ ofÂ statin did not produce any phenotype in wild-type (<italic>ubiad1</italic><sup>+/+</sup>) embryos, it caused a <italic>bar</italic>-like phenotype in embryos heterozygous for <italic>ubiad1</italic> (<italic>ubiad1</italic><sup><italic>+/â</italic></sup>) (<xref rid="fig3" ref-type="fig">Figures 3</xref>Fâ3I). The statin-dependent phenotype in embryos was efficiently rescued by exogenous administration of liposomal CoQ10 (<xref rid="fig3" ref-type="fig">Figures 3</xref>J and 3K and S3C). To address the role of the mevalonate pathway in protection from oxidative stress inÂ vivo, we measured ROS levels in zebrafish embryos treated with HMG-CoA reductase inhibitors. A ROS level increase is detected in statin-treated zebrafish embryos, and this oxidative stress was fully rescued by CoQ10 treatment (<xref rid="fig3" ref-type="fig">FigureÂ 3</xref>L). These data suggest that HMG-CoA reductase and Ubiad1 are on the same metabolic pathway to produce CoQ10 as a potent antioxidant molecule which protects cardiovascular tissues during development.</p>
      </sec>
      <sec id="sec2.3">
        <title>UBIAD1 Synthesizes CoQ10 in the Golgi Compartment</title>
        <p>To determine whether Ubiad1 could be an enzyme responsibleÂ for cellular CoQ10 production, we examined its subcellular localization. Ubiad1 is conserved among species and is predicted to be a transmembrane protein (<xref rid="bib39" ref-type="bibr">Nickerson etÂ al., 2010</xref>). Using human primary ECs, we found that UBIAD1 localizes inÂ an asymmetric perinuclear region that resembles the GolgiÂ compartment (<xref rid="figs4" ref-type="fig">FigureÂ S4</xref>A). Colocalization studies using the Golgi-specific marker TGN46 demonstrate that endogenousÂ UBIAD1 is in the proximity of the Golgi (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>A). Also,Â green fluorescent protein (GFP)-tagged zebrafish Ubiad1 expressed in human ECs localizes in the same perinuclearÂ regionÂ compartment and colocalizes with the Golgi markers,Â GM-130 and Î³-adaptin (<xref rid="fig4" ref-type="fig">Figures 4</xref>B and4C). Further, we observe a rapid redistribution of Ubiad1-GFP proteins in cellsÂ treated with brefeldin A, supporting its Golgi localization (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>D).</p>
        <p>We hypothesized that since UBIAD1 is localized in the GolgiÂ compartment, this enzyme might be a nonmitochondrial CoQ10 prenyltransferase. To test this, we performed subcellular fractionation experiments on human ECs and detected UBIAD1 only in Golgi compartments and not in mitochondria (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>E). We analyzed de novo CoQ10 synthesis in these subcellular fractions by incubating ECs with the hydroxy-4-benzoic acid-<sup>13</sup>C<sub>6</sub> precursor and observed a decrease in CoQ10-<sup>13</sup>C<sub>6</sub> production in Golgi compartments compared to mitochondrial fractions when UBIAD1 expression is reduced (<xref rid="fig4" ref-type="fig">FigureÂ 4</xref>F). These data indicate that UBIAD1 is a CoQ10 biosynthetic enzyme located in the Golgi membrane compartment where large amounts of cellular CoQ10 are normally synthesized (<xref rid="bib27" ref-type="bibr">KalÃ©n etÂ al., 1990</xref>; <xref rid="bib56" ref-type="bibr">Swiezewska etÂ al., 1993</xref>).</p>
      </sec>
      <sec id="sec2.4">
        <title>SCCD Mutations Protect Cardiovascular Tissues from Oxidative Stress by CoQ10 Production</title>
        <p>Mutations in the <italic>UBIAD1</italic> gene are linked to the Schnyder Crystalline Corneal Syndrome (SCCD; OMIM <ext-link ext-link-type="omim" xlink:href="121800">121800</ext-link>) (<xref rid="bib62" ref-type="bibr">Weiss etÂ al., 2007</xref>; <xref rid="bib43" ref-type="bibr">Orr etÂ al., 2007</xref>; <xref rid="bib64" ref-type="bibr">Yellore etÂ al., 2007</xref>). Two common <italic>UBIAD1</italic> mutations found in SCCD patients lead to N102S and D112G substitutions. We generated human UBIAD1 constructs carrying these mutations (UBIAD1-N102S and UBIAD1-D112G) and found that they were able to rescue the loss of Ubiad1 during zebrafish development. We tested these variants for levels of expression and CoQ10 synthesis in human ECs. Compared to wild-type UBIAD1 protein, SCCD variants were expressed at higher levels (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>B). Furthermore, human ECs expressing the UBIAD-SCCD mutant proteins produced higher CoQ10 levels compared to wild-type protein (<xref rid="fig6" ref-type="fig">Figures 6</xref>C and 6D). Intriguingly, SCCD mutations did not affect cholesterol synthesisÂ in human ECs (<xref rid="fig5" ref-type="fig">FigureÂ 5</xref>E). Although it remains unclear why SCCD mutation would results in the SCCD phenotype, these findings suggest that the SCCD variants are effective in CoQ10 production.</p>
      </sec>
      <sec id="sec2.5">
        <title>Ubiad1 and Coq2 Play Different Roles in CoQ10-Mediated Cardiovascular Oxidative Protection</title>
        <p>CoQ10 is a mobile lipophilic electron carrier critical for electron transfer by the mitochondrial inner membrane respiratory chain (<xref rid="bib35" ref-type="bibr">Mitchell, 1961</xref>; <xref rid="bib59" ref-type="bibr">Turunen etÂ al., 2004</xref>; <xref rid="bib12" ref-type="bibr">Duncan etÂ al., 2009</xref>). Primary CoQ10 deficiencies have been associated with mutations in mitochondrial CoQ10 biosynthetic genes, such as <italic>COQ2</italic> (<xref rid="bib48" ref-type="bibr">Salviati etÂ al., 2005</xref>; <xref rid="bib46" ref-type="bibr">Quinzii etÂ al., 2006</xref>). In order to investigate whether the Golgi-localized Ubiad1 and the mitochondrial-localized Coq2 can have different functions inÂ vivo, we knocked-down Coq2 expression during zebrafish development by morpholino (MO) injections. Similar to <italic>Drosophila sbo</italic>/<italic>coq2</italic> mutants (<xref rid="bib33" ref-type="bibr">Liu etÂ al., 2011</xref>), <italic>coq2</italic> morphants are characterized by a general developmental delay, small body, and severe hindbrain edema (<xref rid="figs5" ref-type="fig">Figures S5</xref>AâS5C). These phenotypes do not occur in <italic>bar</italic> mutants or <italic>ubiad1</italic> morphants, and, althoughÂ a strong increase in oxidative stress occurs in <italic>coq2</italic> morphants (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>B), they did not show blood vessel regression (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>A). Therefore, loss of Coq2 leads to oxidative stress, but it does not significantly affect vascular integrity and survival. We measured CoQ9 and CoQ10 levels, and as expected, theyÂ dropped in <italic>coq2</italic> and <italic>ubiad1</italic> morphants, compared to controls, and in double morphants (<xref rid="fig6" ref-type="fig">Figures 6</xref>C and <xref rid="figs5" ref-type="fig">S5</xref>D). Loss of Ubiad1 and Coq2 inÂ vivo unequivocally causes a decrease in CoQ10 levels that possibly increases oxidative damage in different subcellular compartments leading to different embryonic phenotypes.</p>
        <p>To test whether Coq2 might compensate for loss of Ubiad1, we performed rescue experiments by injecting mRNA encoding for Coq2 in <italic>bar</italic> mutants (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D). Although <italic>coq2</italic> mRNA injection could rescue <italic>coq2</italic> morphants (data not shown) it did not rescue <italic>bar</italic> mutants, suggesting that Coq2 does not protect cardiovascular tissues from oxidative stress during zebrafish development. MitoQ is a mitochondria-targeted antioxidant (<xref rid="bib36" ref-type="bibr">Murphy and Smith, 2007</xref>). Due to its selective accumulation within mitochondria, MitoQ only protects against the mitochondrial oxidative damage that is caused in embryos and cells byÂ blocking mitochondrial CoQ10 synthesis through knocking down Coq2 (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>E). However, MitoQ (which will not interact with the Golgi apparatus) did not rescue <italic>bar</italic> mutants (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>D), indicating that the two different subcellularÂ pools of CoQ10 contribute in quite distinct ways to the phenotype.</p>
        <p>To demonstrate the existence of a functional difference between the subcellular pools of CoQ10, we used human primary ECs where we can silence UBIAD1 and COQ2 genes at the same extent. Their silencing causes an increase in oxidative stress and accumulation of oxidative damage (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>E). To analyze the efficiency of UBIAD1 and COQ2 in total CoQ10 biosynthesis, we performed labeled precursor experiments where 4-hydroxybenzoic acid-<sup>13</sup>C<sub>6</sub> was added to human ECs previously transfected with siRNA for UBIAD1 (siUBIAD1) orÂ for COQ2 (siCOQ2) or both (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>F). Silencing of UBIAD1Â or COQ2 individually or together significantly reduced CoQ10-<sup>13</sup>C<sub>6</sub> production. We also confirmed the efficiency of UBIAD1 and COQ2 siRNAs in decreasing endogenous total CoQ10 levels in ECs (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>F). Interestingly, the silencing of the UBIAD1 gene did not significantly interfere with the transcriptional regulation of COQ2 and vice versa, indicating that the effect on CoQ10 levels from the silencing of one gene is not beÂ altered by upregulation of the other (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>G). We then analyzed mitochondrial morphology and viability in ECs that have been silenced for UBIAD1 or COQ2. The absence of COQ2 significantly altered mitochondrial morphology (<xref rid="figs5" ref-type="fig">Figures S5</xref>G and S5H) and mitochondrial membrane potential (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>H), which can indeed be rescued by MitoQ (<xref rid="figs5" ref-type="fig">FigureÂ S5</xref>I). Mitochondrial damage could not be detected in UBIAD1-silenced cells, indicating that the lack of the mitochondrial pool of CoQ10 in COQ2-silenced cells exclusively impaired mitochondrial function.</p>
        <p>High levels of CoQ10 have been found in cellular membranes, including the Golgi and plasma membranes (<xref rid="bib26" ref-type="bibr">Kalen etÂ al., 1987</xref>; <xref rid="bib59" ref-type="bibr">Turunen etÂ al., 2004</xref>). The presence of CoQ10 in nonmitochondrial membranes has been associated with its role in protecting membrane lipids from peroxidation as well as from an extracellular-induced ceramide-dependent apoptotic pathway (<xref rid="bib38" ref-type="bibr">Navas etÂ al., 2007</xref>). We evaluated oxidative degradation of lipids by measuring lipid peroxidation in siUBIAD1-treated cells (<xref rid="fig6" ref-type="fig">FigureÂ 6</xref>I). ECs without a cellular membrane pool of CoQ10 showed twice the level of oxidized fatty acid lipids, indicating a functional role for UBIAD1 in protection from oxidative species specifically localized in cellular but not mitochondrial membrane. We conclude that UBIAD1-derived CoQ10 prevents lipid peroxidation and propose a specific role for UBIAD1 in membrane protection from oxidative damage.</p>
      </sec>
      <sec id="sec2.6">
        <title>UBIAD1 Prevents a Shear Stress/Klf2a/eNOS-Mediated Oxidative Stress Pathway</title>
        <p>A hemodynamic environment, such as shear stress, is known to lead to ROS generation, which is responsible for vascular remodeling and angiogenesis (<xref rid="bib34" ref-type="bibr">Matlung etÂ al., 2009</xref>). Kruppel-like factor 2 (Klf2) is an immediate mediator of hemodynamic forces created by blood flow and regulates flow-dependent blood vessel integrity both in zebrafish and mice (<xref rid="bib31" ref-type="bibr">Lee etÂ al., 2006</xref>; <xref rid="bib40" ref-type="bibr">Nicoli etÂ al., 2010</xref>). By injecting cardiac troponin T2 (<italic>tnnt2</italic>) morpholino to block blood circulation (<xref rid="bib52" ref-type="bibr">Sehnert etÂ al., 2002</xref>) and <italic>klf2a</italic> morpholino (<xref rid="bib40" ref-type="bibr">Nicoli etÂ al., 2010</xref>) in <italic>bar</italic> mutants, we detected a significant delay of the <italic>bar</italic> phenotype as assessed by intersegmental vessels (Se) disintegration (<xref rid="figs6" ref-type="fig">Figures S6</xref>A and S6B). <italic>klf2a</italic> morpholino injection in <italic>barolo</italic> mutants lead to a partial recovery of oxidative stress in ECs (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>C). These data indicate that a Klf2a-dependent shear stress pathway is required for oxidative stress conditions in <italic>bar</italic> mutants and that loss of Ubiad1 inÂ vivo can be protected by impairment of this pathway.</p>
        <p>In human endothelial cells KLF2 has been found to be directly responsible for eNOS expression and signaling (<xref rid="bib51" ref-type="bibr">Searles, 2006</xref>). Recently, a blood-flow-dependent klf2a-NO signaling cascade has been identified in developing zebrafish embryos (<xref rid="bib61" ref-type="bibr">Wang etÂ al., 2011</xref>). Endothelial <italic>nos</italic> isoforms have been well characterized in zebrafish development (<xref rid="bib18" ref-type="bibr">Fritsche etÂ al., 2000</xref>; <xref rid="bib44" ref-type="bibr">Pelster etÂ al., 2005</xref>; <xref rid="bib41" ref-type="bibr">North etÂ al., 2009</xref>; <xref rid="bib61" ref-type="bibr">Wang etÂ al., 2011</xref>). Inhibition of <italic>nos1</italic> (the zebrafish ortholog of mammalian endothelial <italic>Nos</italic>) expression significantly rescued the <italic>bar</italic> mutant phenotype as well as endothelial regression (<xref rid="fig7" ref-type="fig">Figures 7</xref>A and 7B). Since abrogation of <italic>nos1</italic> expression may interfere with HSC development and blood flow we treated <italic>bar</italic> mutants at the onset of oxidative stress (32 hpf) with the selective inhibitor of eNOS activity, N-nitro-L-arginine methyl ester (L-NAME) (<xref rid="bib41" ref-type="bibr">North etÂ al., 2009</xref>). L-NAME treatment promoted a full morphological and functional cardiovascular recovery of a statistically significant number of <italic>bar</italic> mutants (<xref rid="fig7" ref-type="fig">Figures 7</xref>C and 7D and <xref rid="figs6" ref-type="fig">S6</xref>E). This recovery was carefully evaluated for ROS level and altered redox signaling (SNO-Cys staining) in ECs. Blocking of eNOS activity by L-NAME treatment significantly reduced oxidative stress in endothelial cells of <italic>bar</italic>Â embryos (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>E) and restored normal redox signaling (<xref rid="fig7" ref-type="fig">Figures 7</xref>F and <xref rid="figs6" ref-type="fig">S6</xref>E). Pronephric duct cells affected by oxidative stress in <italic>bar</italic> mutants did not improve after L-NAME treatments (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>F). We also evaluated the effect of the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) on <italic>bar</italic> mutants. SNAP treatments did aggravate the <italic>bar</italic> phenotype by increasing oxidative species in these mutant embryos (<xref rid="figs6" ref-type="fig">Figures S6</xref>DâS6F). To test whether the source of ROS in the absence of UBIAD1 was caused by eNOS, we silenced eNOS in primary human ECs. ROS levels could be fully normalized by reducing eNOS expression in siUBIAD1-treated cells (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>G).</p>
        <p>To verify that the NO-forming activity of eNOS was compromised due to the lack of Ubiad1 and Golgi-CoQ10, we measured NOS activity in <italic>bar</italic> mutants and human ECs silenced for UBIAD1. The lack of Ubiad1 drastically reduced the formation of NO in zebrafish embryos (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>H) as well as in human ECs (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>H).</p>
        <p>We measured tissue-specific NO levels in <italic>bar</italic> mutants by imaging DAF-2DA staining in live embryos. NO accumulation was reduced in the notochord (NC) and was completely absent in the bulbus arteriosus (BuA) of <italic>bar</italic> mutants compared with controls (<xref rid="figs6" ref-type="fig">FigureÂ S6</xref>I). All together we show a specific role for Ubiad1 on regulation of eNOS-mediated NO formation in endothelial and cardiovascular cells inÂ vivo.</p>
        <p>These data indicate that the primary source of ROS causing cardiovascular oxidative stress in <italic>bar</italic> mutant as well as in ECs lacking UBIAD1 is dependent on eNOS activity. Therefore, we propose an unexpected functional link in the Golgi compartments between UBIAD1 and COQ10 in regulating eNOS activity and eventually NO signaling during cardiovascular development and homeostasis.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="sec3">
      <title>Discussion</title>
      <sec id="sec3.1">
        <title>Ubiad1 Is a Prenyltranferase Enzyme Required for CoQ10 Biosynthesis in Golgi Membranes</title>
        <p>CoQ10 is an important cellular and mitochondrial redox component and the only endogenously produced lipid-soluble antioxidant (<xref rid="bib4" ref-type="bibr">Bentinger etÂ al., 2010</xref>). Although the genes encoding for the CoQ10 biosynthetic enzymes have been identified in bacteria and yeast, there is still only limited information about these synthetic enzymes in vertebrates (<xref rid="bib59" ref-type="bibr">Turunen etÂ al., 2004</xref>). The rate-limiting enzyme for the biosynthesis of CoQ10 is the enzyme that catalyzes the condensation of the polyisoprenoid chain with the benzoquinone ring. So far, the mitochondrial COQ2 enzyme has been considered the only prenyltransferase able to catalyze this reaction (<xref rid="bib57" ref-type="bibr">Trevisson etÂ al., 2011</xref>). Here, we identified UBIAD1 as a vertebrate CoQ10 prenyltransferase. UBIAD1 contains an UbiA prenyltransferase domain also present in vertebrate COQ2. Although COQ2 encodes a mitochondrial prenyltransferase, we found that UBIAD1 resides in the Golgi compartment where it produces CoQ10. While the presence ofÂ CoQ10 in nonmitochondrial membranes was previously explained by the existence of specific mechanisms for its redistribution within the cell (<xref rid="bib10" ref-type="bibr">Crane and Morre, 1977</xref>; <xref rid="bib25" ref-type="bibr">Jonassen and Clarke, 2000</xref>), our data now formally demonstrate that CoQ10 are synthetized in the Golgi compartment.</p>
        <p>In favor of our hypothesis of a Golgi-synthetized CoQ10, it hasÂ been recently reported that COQ6, COQ7, and COQ9, which are critical enzymes for CoQ10 maturation, are also localized in the Golgi compartment (<xref rid="bib22" ref-type="bibr">Heeringa etÂ al., 2011</xref>). Similarly, these authors suggested that the Golgi-localized pool of CoQ10 may function in specific cells as an essential antioxidant for plasma membrane lipids that are normally derived from the Golgi compartment.</p>
        <p>In this work, we demonstrated that the two distinct ubiquinone prenyltransferases act to resolve different molecular functions inside the cells and in living organisms. We found that COQ2-mediated CoQ10 production is mainly for mitochondrial respiratory chain function and energy production, whereas UBIAD1-mediated CoQ10 production is important for membrane redox signaling and protection from lipid peroxidation.</p>
      </sec>
      <sec id="sec3.2">
        <title>Ubiad1 and CoQ10: An Antioxidant System Controlling Redox Cellular Membrane in Cardiovascular Tissues</title>
        <p>Oxidative damage is caused by an imbalance between the production of ROS and the antioxidant network. Although ROS are predominantly implicated in causing cell damage and premature aging via oxidation of DNA, lipids, and proteins, they also play a major physiological role in several aspects of intracellular signaling and regulation, especially in cardiovascular tissues (<xref rid="bib21" ref-type="bibr">Hare and Stamler, 2005</xref>; <xref rid="bib29" ref-type="bibr">Kuster etÂ al., 2010</xref>). Therefore, heart, endothelial, and vascular smooth-muscle cells need an efficient antioxidant network to balance ROS levels. We have shown a set of genetic and cellular data that reveal an unexpected role for UBIAD1 as an essential antioxidant gene with important functions in the protection of heart and endothelial cells from oxidative stress at the level of cellular membranes by producing CoQ10 in the Golgi for distribution to nonmitochondrial membranes throughout the cell. In addition to its crucial role in oxidative phosphorylation, CoQ10 plays another vital role in cellular function as an antioxidant molecule. The antioxidant nature of CoQ10 is derived from its function as an electron carrier: in this role, CoQ10 continually shuttles between oxidized and reduced forms. As it accepts electrons, it becomes reduced. As it gives up electrons, it becomes oxidized. In its reduced ubiquinol form, the CoQ10 molecule will quite easily give up one electron, and thus act as an antioxidant. In such a way, CoQ10 inhibits lipid peroxidation by acting as a chain breaking antioxidant. Moreover, CoQH<sub>2</sub> reduces the initial lipid peroxyl radical, with concomitant formation of ubisemiquinone and an alkyl peroxide. This quenching of the initiating peroxyl radicals thereby prevents the propagation of lipid peroxidation and protects not only lipids, but also proteins from oxidation. In addition, the reduced form of CoQ10 might also contribute to the stabilization of the plasma membrane, regenerating antioxidants such as Î±-tocopherol. A crucial role in all these processes is played by NAD(P)H-dependent reductase(s) acting at the plasma membrane to regenerate the reduced ubiquinol form of CoQ10, contributing to the maintainance of its antioxidant properties (<xref rid="bib38" ref-type="bibr">Navas etÂ al., 2007</xref>). This finding also opens an interesting link among cellular redox-state and metabolic pathways such as the mevalonate pathway.</p>
      </sec>
      <sec id="sec3.3">
        <title>An Essential Function for Ubiad1/CoQ10 in Regulation of NO Signaling</title>
        <p>We have demonstrated that UBIAD1 protects cardiovascular tissue from ROS-mediated oxidative stress by producing CoQ10 located in Golgi and plasma membranes. Major enzymatic pathways responsible for the generation of ROS in cardiovascular tissues are mainly NADPH oxidases and eNOS (<xref rid="bib5" ref-type="bibr">Browning etÂ al., 2012</xref>). By using drug inhibition and gene inactivation approaches, we identify eNOS dysfunction as the primary causeÂ of ROS increase in <italic>bar</italic> mutant and UBIAD1-silenced human ECs. The NO synthetized by eNOS is an essential factorÂ for cardiovascular development and homeostasis in vertebrates (<xref rid="bib1" ref-type="bibr">Alp and Channon, 2004</xref>; <xref rid="bib44" ref-type="bibr">Pelster etÂ al., 2005</xref>; <xref rid="bib41" ref-type="bibr">North etÂ al., 2009</xref>; <xref rid="bib61" ref-type="bibr">Wang etÂ al., 2011</xref>). It has been suggested that CoQ10 might have a positive role in modulating NO-related pathways by recoupling eNOS in endothelial cells (<xref rid="bib54" ref-type="bibr">Stuehr etÂ al., 2001</xref>; <xref rid="bib6" ref-type="bibr">Chew and Watts, 2004</xref>; <xref rid="bib58" ref-type="bibr">Tsai etÂ al., 2012</xref>). eNOS isÂ a âL-arginine, NADPH:oxygen oxidoreductases, NO-forming enzymeâ (EC 1.14.13.39) that couples reduction of molecular oxygen to L-arginine oxidation and generation of L-citrulline and NO. eNOS controls the flowÂ of electrons donated by NADPH to flavins FAD and FMN in theÂ reductase domain of one monomer through BH4 to theÂ ferrous-dioxygen complex (Fe) inÂ the oxygenase domain. WhenÂ NADPH and BH4 cofactors are limiting, electron transfer becomes uncoupled from L-arginine oxidation, the ferrousâdioxygen complex dissociates, and superoxide (<sup>â</sup>O<sub>2</sub><sup>â</sup>) is generated from the oxygenase domain (<xref rid="bib50" ref-type="bibr">Schmidt and Alp, 2007</xref>).</p>
        <p>Our data indicate that <italic>barolo</italic> mutants lacking the Golgi pool of CoQ10 die due to the accumulation of oxidative damage in cardiovascular tissues caused by ROS produced by eNOS. We suggest a mechanism whereby UBIAD1 is required in the Golgi compartment to produce CoQ10 as an important cofactor for eNOS-mediated NO production (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>I). This model could fit with the oxido-reductive properties of CoQ10 and eNOS: the electron flux inside eNOS that is mandatory to produce NO from L-arginine might require CoQ10, together with NADPH and BH4. Such function would not be very different from what CoQ10 does in the mitochondrial electron transport chain (ETC) coupling electron transfer between an electron donor (such as NADH) and an electron acceptor (such as O<sub>2</sub>) with the transfer of H<sup>+</sup> ions across the mitochondrial inner membrane. In the Golgi membranes, the flow of electrons within eNOS transfers electrons from NADPH to the flavins FAD and FMN, which have the capacity to reduce molecular oxygen. If the ETC is disturbed, such as in the absence of UBIAD1/CoQ10, the ferrous-dioxygen complex dissociates, and O<sup>â</sup><sub>2</sub> is generated from the FMN oxygenase domain (<xref rid="bib32" ref-type="bibr">Liu etÂ al., 2002</xref>; <xref rid="bib47" ref-type="bibr">Rigoulet etÂ al., 2011</xref>). In cardiovascular tissues, the CoQ10 produced by UBIAD1 in the Golgi compartment may be an important cofactor to maintain eNOS in a coupled conformation (e.g., required to produce physiological NO) and, eventually, quench leaking-uncoupled electrons. We speculate that when UBIAD1/CoQ10 in the Golgi compartment is absent or decreased (<italic>bar</italic> mutants and siUBIAD1-treated cells) eNOS switches to an âuncoupledâ conformation, producing oxidative species instead of NO and causing cardiovascular oxidative damage (<xref rid="fig7" ref-type="fig">FigureÂ 7</xref>I). Further experiments need to be done to assess this hypothesis as well as the possibility that other NOS (e.g., nNOS) could be affected by the lack of Ubiad1 inÂ vivo.</p>
        <p>In summary, our study places UBIAD1 in a pathway with important therapeutic implications for cardiovascular failure, such as the opportunity to decrease oxidative damage and counteract some of the side effects of statins. In addition, pharmacological or genetic stimulation of UBIAD1, as a CoQ10 biosynthetic enzyme, represents a promising therapeutic approach for antioxidant-related diseases such as aging and cancer.</p>
      </sec>
    </sec>
    <sec sec-type="methods" id="sec4">
      <title>Experimental Procedures</title>
      <sec id="sec4.1">
        <title>Zebrafish Strains, Mapping, Genotyping</title>
        <p>Embryos and adult fishes were raised and maintained under standard laboratory conditions. <italic>bar</italic><sup>s847</sup> and <italic>bar</italic><sup>t31131</sup> mutants were generated by ENU mutagenesis as previously described (<xref rid="bib24" ref-type="bibr">Jin etÂ al., 2007</xref>).</p>
      </sec>
      <sec id="sec4.2">
        <title>Oxidative Stress Analyses in Zebrafish Embryos and Cells</title>
        <p>Oxidative damage was detected by immunofluorescence on agarose sections of zebrafish embryos with the following markers: anti-8-hydroxy-2â²-deoxyguanosine (1:500, Abcam) and anti-S-nitroso-cysteine (1:250, Sigma).</p>
        <p>ROS levels were quantitated in isolated human (HUAEC) and zebrafish (<italic>Tg(Kdrl:GFP)</italic><sup><italic>s843</italic></sup>) endothelial cells with CellROX Deep Red Reagent (Invitrogen; 2.5Â Î¼M) and analyzed by FACS.</p>
      </sec>
      <sec id="sec4.3">
        <title>Generation of Human SCCD Mutation in UBIAD1</title>
        <p>Constructs containing the SCCD mutation N102S and D112G were introduced in pCS2+ plasmids and used for expression in zebrafish embryos as well as human ECs.</p>
      </sec>
      <sec id="sec4.4">
        <title>NO Levels and NOS Activity in Zebrafish Embryos and Human ECs</title>
        <p>NOS activity was assayed using the NOS Activity Assay Kit (Cayman Chemicals). NO levels were detected using the DAF-2 DA (Calbiochem).</p>
      </sec>
      <sec id="sec4.5">
        <title>Cell Culture Experiments</title>
        <p>Human primary EC were purchased from Lonza and cultured according to the manufacturerâs protocols (Lonza). Cells were electroporated with siRNA (Dharmacon).</p>
      </sec>
      <sec id="sec4.6">
        <title>HPLC Analyses</title>
        <p>Samples for HPLC-MS analysis were zebrafish embryos (nÂ = 25) or human HUAEC (2Â Ã 10<sup>6</sup> cells). CoQ10 and CoQ9 levels were detected by HPLC-MS or HPLC-UV (as indicated). Total cholesterol from zebrafish embryos was analyzed by HPLC-UV. 4-Hydroxy-benzoic acid-<sup>13</sup>C<sub>6</sub> was stocked in Dulbecco's modified Eagle's medium (DMSO) and dissolved in cell culture medium (1Â mM) or microinjected in zebrafish embryo at one cell stage (2Â mM). ECs or embryos were extracted after 48 or 72Â hr, respectively, after labeled precursor administration. Extracts were quantified by HPLC-MS as described.</p>
      </sec>
      <sec id="sec4.7">
        <title>Exogenous CoQ10 and Vitamin K Administration</title>
        <p>All chemicals and solvents for liposomal CoQ10 and Vitamin K formulation were purchased from Sigma Aldrich and Avanti Polar Lipids. Liposomal SINAMIT was a gift from Dr. Franz Enzmann (MSE Pharmazeutika GmbHT), liposomal LiQsorb was from Tishcon Corp. MitoQ was synthetized as previously reported (<xref rid="bib36" ref-type="bibr">Murphy and Smith, 2007</xref>). All CoQ10 and vitamin K formulations were tested for toxicity and microinjected at specific concentrations into zebrafish embryos at one cell stage.</p>
        <p>For detailed procedure of refer to <xref rid="dtbox1" ref-type="boxed-text">Extended Experimental Procedures</xref>.</p>
        <p>
          <boxed-text id="dtbox1">
            <label>Extended Experimental Procedures</label>
            <sec id="dtbox1sec1">
              <title>Zebrafish Strains, Mapping, and Genotyping</title>
              <p>Following zebrafish lines were used for these studies: <italic>bar</italic><sup>s847</sup>, <italic>bar</italic><sup>t31131</sup>, wild-type AB/TAB, <italic>Tg (kdrl:GFP)</italic><sup><italic>s843</italic></sup>, <italic>Tg (fli1a:EGFP)</italic><sup><italic>y1</italic></sup>, <italic>Tg(Kdrl:mCherry)</italic><sup><italic>uto2</italic></sup></p>
              <p>Bulked segregate analysis was performed as previously described (<xref rid="bib71" ref-type="bibr">Michelmore etÂ al., 1991</xref>). Fine mapping of the t31131 mutation was performed with marker z22307 close to the mutation on contig: Zv8_scaffold 1100 of the zebrafish genome. Sequencing the coding region of the <italic>ubiad1</italic> gene (ubiad1, LOC554810) revealed a t &gt; a mutation at nucleotide 123 in <italic>bar</italic><sup>t31131</sup> and a t &gt; a mutation at nucleotide position 185 in <italic>bar</italic><sup>s847</sup>.</p>
              <p>Genotyping were performed by two sequential PCR, which products were analyzed by sequencing. We used following primers: first PCR: FW: 5â²-CCTGTGTGTGTTGTGATCG-3â²; RW: 5â²-TAGGTGTTGACCAGGTTTCC-3â², second PCR: FW 5â²-TGTAAAACGACGGCCAGTCTGGATGCAGGAGATGAAG-3â²; RW: 5â²- AGGAAACAGCTATGACCATCCAGCTTGTAGGCCAGAG-3â².</p>
            </sec>
            <sec id="dtbox1sec2">
              <title>Morpholino Microinjections</title>
              <p>Morpholinos or mRNAs were injected at one cell-stage in different strains and phenotype was assayed between 48â72 hpf as described. Gene knockdown in zebrafish embryos was performed by microinjection of the following morpholinos: Control (5â²-CCTCTTACCTCAGTTACAATTTATA-3â²; 0.2Â mM), ubiad1 (5â²- GAAGCCAATCGGTATATTCACCTCC-3â²; 0.2Â mM), tnnt2a (5â²- CATGTTTGCTCTGATCTGACACGCA-3â²; 0.2Â mM; <xref rid="bib52" ref-type="bibr">Sehnert etÂ al., 2002</xref>), klf2a (5â²-GGACCTGTCCAGTTCATCCTTCCAC-3â²; 0.2Â mM; <xref rid="bib40" ref-type="bibr">Nicoli etÂ al., 2010</xref>), coq2 (5â²-GTGTGAAATACAGAAAGCTCACCTA-3â²; 0.2Â mM), nos1 (5â²- TTAATGACATCCCTCACCTCTCCAC-3â²; 0.2Â mM; <xref rid="bib41" ref-type="bibr">North etÂ al., 2009</xref>). Morpholinos were synthetized from GeneTools and dissolved in nuclease-free water. Primers for testing ubiad1 morpholino were designed on zebrafish ubiad1 (GeneBank accession number: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_001199726">NM_001199726</ext-link>) and are FW: 5â²- CCGCAGGACGTGGTGATGTTTG-3â²; REW: 5â²- GTCTGAGTCCATGTCCCGCG-3â²). Primers for testing coq2 morpholino were designed on zebrafish coq2 (GeneBank accession number: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_001089486">NM_001089486</ext-link>) and are: FW: 5â²-TTCAAAATATGTCACGGTGCT-3â²; RW: 5â²-GTCCTCGGGTCTGTTGATGT-3â². As control Î²-actin was detected with following primers: FW: 5â²- GTATCCACGAGACCACCTTCA-3â²; RW: 5â²-GAGGAGGGCAAAGTGGTAAAC-3â².</p>
            </sec>
            <sec id="dtbox1sec3">
              <title>mRNA Microinjection</title>
              <p>Embryos from <italic>bar</italic> heterozygote intercrosses were injected at one-cell stage with 80pg of mRNA (mMessage Machine, Ambion) encoding for the indicated proteins. We also included a control mRNA for fluorescent protein H2B-cherry (50pg) in each injection.</p>
            </sec>
            <sec id="dtbox1sec4">
              <title>Transplantation Experiments</title>
              <p>Transplantation experiments were performed as previously described (<xref rid="bib67" ref-type="bibr">Ho and Kane, 1990</xref>). Donor embryos of the genotype Tg(fli1a:GFP)<sup>y1</sup> were injected with 70Â kDa Tetramethyl Rhodamine (TAMRA; Molecular Probes) at the one-cell stage and used forÂ transplantations at the predome stage. Acceptor embryos were from wild-type or Tg(Kdrl:mCherry)<sup>uto2</sup> lines as specifically indicated.</p>
            </sec>
            <sec id="dtbox1sec5">
              <title>Generation of the Zebrafish Transgenic Line <italic>Tg(kdrl:Ubiad1-2A-mCherry)</italic><sup><italic>uto 35</italic></sup> and Analysis of Ubiad1 Endothelial Cell Autonomous Effect</title>
              <p>The Tol2-based kdrl:Ubiad1-2A-mCherry construct has been assembled by using the Tol2 Kit and three-fragment gateway recombination cloning strategy (<xref rid="bib68" ref-type="bibr">Kwan etÂ al., 2007</xref>). For 5â² entry cloning, the 6.4Kb Kdrl promoter was amplified from genomic DNA of wild-type zebrafish by PCR with following primers containing appropriate attB4 and attB1 sites (5â²-GGGGACAACTTTGTATAGAAAAGTTGAAGCTTTTTCTTTTATTTAA-3â² and 5â²-GGGGACTGCTTTTTTGTACAA ACTTGTTTGTCTGTTAAAATAACGT-3â², respectively). The PCR product was then cloned into pDONRP4-P1R by BP reaction to obtain p5E-Kdrl. For the middle entry cloning zebrafish ubiad1 was amplified with following primers containing appropriate attB1 and attB2 sites: 5â²-GGGGACAAGTTTGTACAAAAAAGCAGGCTAGGAGATGAAGCCGGCTGCGCTTTC-3â² and 5â²- GGGGACCACTTTGTACAAGAAAGCTGGGTAAGAAATTCACAATAACGGCAGGCT-3â², respectively) and cloned into pDONR221 by BP reaction. The 3â² entry clone was p3E-2A-mCherrypA. Entry vectors were assembled together with the pDestTol2pA2 by LR reaction to create the expression vector pDestTol2-Kdrl-Ubiad1-2A-mCherry-pA. The pDestTol2-Kdrl-Ubiad1-2A-mCherrypA was mixed with mRNA for Tol2 transposase and microinjected into one-cell stage wild-type embryos. Injected embryos were raised to adulthood and founders were screened for red fluorescence in the vasculature. The transgene integration was also confirmed by PCR on genomic DNA with forward primer on <italic>ubiad1</italic> sequence (5â²- TGCACAGCAACAACACGGGG â3â²) and reverse primer on mCherry sequence (5â²- CGAACTCGTGCCGTTCACGG â3â²). As control Î²-actin gene was detected with following primers: FW: 5â²- GTATCCACGAGACCACCTTCA-3â²; RW: 5â²-GAGGAGGGCAAAGTGGTAAAC-3â². The transgenic fish line nomenclatures <italic>uto35</italic> was approved by the Zebrafish Nomenclature Committee of ZFIN (<ext-link ext-link-type="uri" xlink:href="http://zfin.org">http://zfin.org</ext-link>). Microinjection of control and ubiad1 was performed as previously described in intercrossed from Tg(Kdrl:GFP)<sup>s843</sup> and Tg(kdrl:Ubiad1-2A-cherry)<sup>uto 35</sup> lines. After MO injection, double <italic>Tg[(Kdrl: GFP)</italic><sup><italic>s843</italic></sup><italic>:(kdrl:Ubiad1-2A-cherry)</italic><sup><italic>uto 35</italic></sup><italic>]</italic> or single <italic>Tg(Kdrl: GFP)</italic><sup><italic>s843</italic></sup> were scored for embryos showing the <italic>barolo</italic> phenotype as measurement of <italic>ubiad1</italic> morpholino penetrance.</p>
            </sec>
            <sec id="dtbox1sec6">
              <title>Whole-Mount In Situ Hybridization</title>
              <p>Whole mount inÂ situ hybridization was performed as previously described (<xref rid="bib74" ref-type="bibr">Santoro etÂ al., 2009</xref>). The following oligonucleotides wereÂ used for antisense digoxigenin labeled probe: FW: 5â²-CCGCAGGACGTGGTGATGTTTG-3â², RW: 5â²- CGCGGGACATGGACTCAGAC-3â².</p>
            </sec>
            <sec id="dtbox1sec7">
              <title>TUNEL Assay</title>
              <p>The TUNEL cell death assay was carried out using the âIn Situ Cell Death Detection Kitâ TMR Red (Roche) as previously reported (<xref rid="bib49" ref-type="bibr">Santoro etÂ al., 2007</xref>). Zebrafish sections were analyzed by confocal microscopy. Acquisitions were quantitated with appropriate image processing tools as described in the âImage acquisition section.â</p>
            </sec>
            <sec id="dtbox1sec8">
              <title>Western Blot Analyses on Zebrafish Embryos</title>
              <p>Zebrafish embryos were collected and deyolked in a solution of PBS1X supplemented with complete protease inhibitors cocktail (Roche). For Ubiad1 detection, embryos were lysed in RIPA buffer. 50Â Î¼g of total extracts were not boiled and loaded on 12% SDS-PAGE denaturing gel. Western blot analyses were performed with mouse anti-UBIAD1 (9D4; 1:500).</p>
            </sec>
            <sec id="dtbox1sec9">
              <title>Extraction of Single Cells from Zebrafish Embryos for Quantitation of Cellular ROS Level</title>
              <p>Tg (kdrl:GFP)<sup>s843</sup> embryos were dissociated into single cells by following procedure (modified from <xref rid="bib66" ref-type="bibr">Covassin etÂ al., 2006</xref>). Embryos (nÂ = 20) were collected and deyolked with forceps in sterile PBS supplemented with complete protease inhibitor cocktail (Roche). Embryos were then transferred into a 24 wells plate with 500Â Î¼l of Protease solution (0.25% trypsin, 1Â mM EDTA, pH 8.0, sterile PBS) and 30Â Î¼l of Collagenase P (100Â mg/ml, Roche). Embryos were incubated at 28Â°C for 30â and homogenized every 10âwith a 200Â Î¼l pipette tip. Lysis was blocked with 500Â Î¼l of FBS (Invitrogen) and cells were collected into a prechilled Eppendorf tubes and centrifugated at 450rcf / 4Â°C for 5â². Supernatant was removed and cells were washed with 1Â ml of HBSS (GIBCO). Cells were then incubated with 1Â ml of cold HBSS containing CellROX probe for 10â and analyzed at appropriate fluorescence wavelength on FACSCalibur (Becton Dickinson) according to manufactureâs protocol. All procedures including the CellROX probe were carried out on dark.</p>
            </sec>
            <sec id="dtbox1sec10">
              <title>Analysis of NADP/NADPH Ratio in Zebrafish Embryos</title>
              <p>The NADP/NADPH ratio assay was performed on zebrafish tissue extracts using the NADP/NADPH assay kit (Abcam). Samples were extracted in 400Â Î¼l of the recommended extraction buffer and 50Â Î¼l were processed following instructions. OD450 measurements were made on a Glomax Multi Detection System (Promega) plate-reader. OD450 measurements were converted to nmol/sample using a standard curve and values were used for ratio as previously reported (<xref rid="bib42" ref-type="bibr">OâNeill and Reddy, 2011</xref>).</p>
            </sec>
            <sec id="dtbox1sec11">
              <title>Chemical Treatments</title>
              <p>Chemicals for zebrafish treatments were dissolved in sterile water or dimethyl sulfoxide (DMSO). Zebrafish embryos were treated with the following drugs: Statins (Mevastatin, Simvastatin and Mevinolin, 5 or 500nM; Sigma), from 48 to 72 hpf or as otherwise indicated; Squalene Inhibitor (SQI, 10Â Î¼M; Calbiochem) from 32 hpf to 72 hpf, GGTI-2133 and FTI-277 (10â50Â Î¼M, Sigma) from 54 hpf to 72 hpf; NÏ-Nitro-L-arginine methyl ester hydrochloride (L-NAME) (500Â Î¼M, Sigma) from 32 to 65 hpf or as otherwise indicated, S-nitroso-N-acetyl-DL-penicillamine (SNAP) (100Â Î¼M, Sigma) from 48 hpf to 65 hpf.</p>
            </sec>
            <sec id="dtbox1sec12">
              <title>Zebrafish and Human UBIAD1 Constructs</title>
              <p>Zebrafish ubiad1 (GeneBank accession number: <ext-link ext-link-type="uri" xlink:href="ncbi-p:XM_681613.2">XM_681613.2</ext-link>) and human UBIAD1 (GeneBank accession number <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_013319.2">NM_013319.2</ext-link>) cDNAs were amplified using the following primers: FW: 5â²-ATGAAGCCGGCTGCGCTTTC-3â²; RW: 5â²-TCACAATAACGGCAGGCT-3â²; FW: 5â²-ATGGCGGCCTCTCAGGTCCTG-3â²; RW: 5â²-TTAAATTTTGGGCAGACTGCCTGCTGG-3â² respectively and cloned in PCS2+ vector. All constructs were then amplified and subcloned into pGEM T-easy vector with following primers: human UBIAD1 forms:</p>
              <p>FW: 5â²-AAAGAATTCTCCATGGCGGCCTCTCAG-3â², RW: 5â²-GAAAGATCTAATTTTGGGCAGACTGCC-3â², zebrafish ubiad1: FW: 5â²Â - AAAGAATTCGAGATGAAGCCGGCTGCG-3â², RW: 5â²-TTTGGATCCCAATAACGGCAGGCTGCC-3â². Constructs were then cloned into pEGFP-N3 vector with restriction enzymes. All constructs were tested for comparable levels of expression and toxicity in cells.</p>
            </sec>
            <sec id="dtbox1sec13">
              <title>Human SCCD Mutant UBIAD1 Constructs</title>
              <p>Human SCCD mutant isoforms UBIAD1-N102S and UBIAD1-D112G were generated with QuickChange site-directed mutagenesis kit (Stratagene) with following primers: D112G FW: 5â²- CTTTTCCAAGGGCATTGGCCACAAAAAGAGTGATG-3â², RW: 5â²- CATCACTCTTTTTGTGGCCAATGCCCTTGGAAAAG-3â²) and N102S: FW:5â²-CGGGGCCGGTAATTTGGTCAGCACTTACTATGACTTTTCC-3â², RW:5â²-GGAAAAGTCATAGTAAGTGCTGACCAAATTACCGGCCCCG-3â².</p>
              <p>All constructs were then amplified and subcloned into pGEM T-easy vector with following primers: human UBIAD1 forms: FW: 5â²-AAAGAATTCTCCATGGCGGCCTCTCAG-3â², RW: 5â²-GAAAGATCTAATTTTGGGCAGACTGCC-3â², zebrafish ubiad1: FW: 5â² - AAAGAATTCGAGATGAAGCCGGCTGCG-3â², RW: 5â²-TTTGGATCCCAATAACGGCAGGCTGCC-3â². Constructs were then sub-cloned into pCS2+ vector with specific restriction enzymes. All constructs were tested for comparable levels of expression and toxicity in cells.</p>
            </sec>
            <sec id="dtbox1sec14">
              <title>Transfection of Human Primary Endothelial Cells</title>
              <p>4.0 x10<sup>5</sup> human primary EC (P3-P4) were transfected with 50 or 100 pmoles of control-, UBIAD1-siRNA and COQ2-siRNA (siGENOME, Dharmacon) or 3Â Î¼g of expression constructs using Amaxa protocols (Nucleofector kit: VPB-1002, Nucleofector program: U-001). pCDNA-GFP (3Â Î¼g) was used as control of electroporation each time.</p>
            </sec>
            <sec id="dtbox1sec15">
              <title>Subcellular Fractionation Experiments in Endothelial Cells</title>
              <p>HUAEC (5Â Ã 10<sup>5</sup> cells) were transfected with siRNA (60 pmoles) as previously stated. 2Â Ã 10<sup>7</sup> cells were trypsinized and pelleted by centrifugation at 800rpm for 5â² and washed twice with cold PBS. Pellet was resuspended with mitochondria isolation reagent A (Mitochondria Isolation Kit Thermo Scientific), vortexed at 15Hz for 5Â s and incubated on ice for 5Â min. Cell suspension was then transferred to a prechill Dounce Grinder (Sigma) and homogenized on ice (30 strokes/3 times). Lysed cells were transferred to a new tube and mixed with 800Â Î¼l of mitochondria isolation reagent C (Mitochondria Isolation Kit; Thermo Scientific). Cell lysate was centrifuged at 700Â g for 10Â min at 4Â°C to separate membrane fractions (pellet) from mitochondria and cytosol (supernatant). Membrane fraction was then suspended in reagent A and centrifuged at 500Â g for 10Â min at 4Â°C (<xref rid="bib69" ref-type="bibr">Lindner, 2001</xref>). Pellet containing Golgi/ER/endosome fractions were then subjected to protein or lipid extractions as described. Supernatant containing mitochondria and cytosol fractions was transferred to a new tube and centrifuged at 3,000 <italic>g</italic> for 15Â min at 4Â°C. The upper phase was discarded (cytosol) and mitochondria pellet was washed twice with 500Â Î¼l reagent C and centrifuged at 12,000 <italic>g</italic> for 5Â min at 4Â°C (<xref rid="bib72" ref-type="bibr">Rice and Lindsay, 1997</xref>). Pellet containing mitochondria was subjected to protein or lipid extractions as described.</p>
            </sec>
            <sec id="dtbox1sec16">
              <title>Western Blot Analyses on Human Endothelial Cells</title>
              <p>For western blot analysis whole-cell extracts or subcellular fractions were lysed in RIPA Buffer and different amount of total protein or fractions were loaded on 4%â15% SDS-PAGE denaturing gel under reducing conditions. For Ubiad1 analyses samples were not boiled before loading on gel. Subsequent procedures were performed as described in <xref rid="bib49" ref-type="bibr">Santoro etÂ al., 2007</xref>. Western blot analyses were performed with following primary antibodies: mouse anti-UBIAD1 (9D4; 1:500), goat anti TERE1 (UBIAD1)-N16 (1:250; SantaCruz), mouse anti Î²actin (1:5,000; Sigma), mouse anti Rab11 (1:1,000; BD Biosciences), rabbit anti HADHA (<underline>H</underline>ydroxyacyl-Co<underline>A</underline>
<underline>D</underline>ehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA <underline>H</underline>ydratase (trifunctional protein), <underline>A</underline>lpha subunit) (1:5,000; Abcam).</p>
            </sec>
            <sec id="dtbox1sec17">
              <title>UBIAD1 Monoclonal Antibody Production</title>
              <p>Monoclonal antibody against UBIAD1 (clone 9D4) was produced in our laboratory by immunizing mice with recombinant GST-Ubiad1 (aa 96-126) fusion protein and its reactivity was characterized in ELISA, completion with peptide, western blot and immunofluorescence as described in the text.</p>
            </sec>
            <sec id="dtbox1sec18">
              <title>UBIAD1 Localization in Endothelial Cells</title>
              <p>For UBIAD1 localization studies human primary endothelial cells were transfected (where specified) and plated on fibronectin-coated glass slides. After 48Â hr cells were fixed in 4% paraformaldehyde and incubated with the following primary antibodies: mouse anti UBIAD1 (1:5, 9D4), rabbit anti TGN46 (1:25, Abcam), mouse anti Î³âAdaptin (1:100; BD Biosciences), mouse anti GM130 (1:100, BD Biosciences). Secondary antibodies were from Alexa Fluor (Invitrogen). Nuclei were stained with Hoechst. Localization studies were confirmed by treatment of cells with Brefeldin A (Sigma, 36Î¼M) for 3h in cell culture medium.</p>
            </sec>
            <sec id="dtbox1sec19">
              <title>Mitochondria Staining in Cultured Endothelial Cells</title>
              <p>Mitochondria morphology was detected on human primary ECs by immunofluorescence with mouse anti-60Â kDa mitochondrial protein antibody (1:100; Abcam). Hoechst was used for nuclei staining. ECs were then analyzed at confocal microscopy.</p>
            </sec>
            <sec id="dtbox1sec20">
              <title>HPLC Analyses</title>
              <p>Samples (cells or zebrafish embryos) were lysed in 500Î¼l water-ethanol 2:3 and a 5Î¼l lysate aliquot was analyzed for protein content according to the Bradford assay. Lysates were extracted twice with 500Î¼l of hexane and the resulting organic phase was evaporated dry under reduced pressure. The residue was dissolved in 200Â Î¼l of methanol, sonicated and lastly centrifuged (12,000Â rpm, 5Â min). The upper layer was then immediately subjected to HPLC analyses. A standard amount of CoQ6 (Spectra2000) was added to the cell or embryo lysates as an internal standard for the assessment of the recovery percentage. Quantitation of CoQ10, CoQ9, cholesterol, Vitamin K and CoQ10-<sup>13</sup>C<sub>6</sub>, CoQ9-<sup>13</sup>C<sub>6</sub> analytes was done by external calibration curves and corrected to % recovery evaluated on CoQ6.</p>
              <p>HPLC-UV analyses for CoQ10 and cholesterol from zebrafish embryo extracts were performed on a Waters Alliance System (separations module: 2695 model) equipped with a photodiode array detector (model 2998) and a Waters Symmetry C<sub>18</sub> reverse phase column (4.6Â mm Ã 75Â mm, 3.5Â Î¼m); pure methanol was used for the separation of lipid extracts (flow rate: 1Â ml/min; run time: 45Â min). HPLC-MS analyses for CoQ10 and cholesterol from zebrafish embryo extracts were performed on a liquid-chromatography/electrospray ionization tandem mass spectrometry system (HPLC-ESI-MS, Waters 515 HPLC pump-3100 mass detector); 5Â mM of ammonium formate was added to the eluent (100% methanol) to promote the ionization of the analytes (<xref rid="bib73" ref-type="bibr">Ruiz-JimÃ©nez etÂ al., 2007</xref>).</p>
              <p>HPLC MS/MS analyses for Vitamin K2 from zebrafish embryo and cell extracts were done on API3200 HPLC-MS system equipped with APCI ion source (Applied Biosystems). Waters Symmetry C<sub>18</sub> reverse phase column (4.6Â mm Ã 75Â mm, 3.5Â Î¼m particle size) was used with 100% methanol as the mobile phase (isocratic conditions, time course 60Â min). Acquisitions were recorded in TIC (Total Ion Current) and SIM (Select Ion Monitoring) mode.</p>
              <p>HPLC-MS analyses for CoQ10 and CoQ10-<sup>13</sup>C<sub>6</sub> from cell extracts were done on an Ultimate 3000 HPLC (Dionex) coupled to a high resolving power mass spectrometer LTQ Orbitrap (Thermo Scientific), equipped with an atmospheric pressure interface and an ESI ion source. Samples were analyzed using an RP C4 column (Phenomenex Jupiter, 150Â Ã 2Â mm, 5Â Î¼m particle size, Phenomenex) at a 200Â Î¼L/min flow rate. The isocratic mobile phase composition was 95% of methanol and 5% of 10Â mM aqueous formic acid. The injection volume was 20Â Î¼L. The tuning parameters adopted for the ESI source were: source voltage 4.5 kV, capillary voltage 48.00 V, and tube lens voltage 180 V. The heated capillary temperature was maintained at 265Â°C. The mass accuracy of the recorded ions (versus the calculated ones) was Â± 5Â mmu (milli-mass units). Analyses were run using both full MS (300â1,000 m/z range) and MS/MS acquisition in the positive ion mode. Analytes were quantified in the full MS mode as [M+Na]<sup>+</sup>. Five-points calibration curves were done by standard addition of the analytes on a cell lysate matrix in the range 0â500Â ng/ml.</p>
              <p>If not otherwise stated all chemicals used for extractions and HPLC analyses were from Sigma.</p>
            </sec>
            <sec id="dtbox1sec21">
              <title>Exogenous CoQ10 and Vitamin K2 Administration</title>
              <p>The composition of liposomes used for rescue tests was typically: 65% POPC (2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine), 5% DPPG (1,2-Dipalmitoyl-sn-glycero-3-phosphoglycerol), 25% cholesterol, 5% ubiquinone or menaquinone. A mixture of the appropriate amounts of phospholipids and cholesterol was dissolved in chloroform and the solution evaporated to dryness under reduced pressure (20 mbar) on a rotary evaporator (temperature of the bath 30Â°C). The lipid film was subsequently flowed with nitrogen for 2Â hr to remove residual traces of organic solvents. The film was then heated to 65Â°C and hydrated with the dialysis buffer for 10Â min. The resulting lipid suspension was sonicated two times for 20Â s at a frequency of 20 kHz and finally dialysed overnight. The mean hydrodynamic diameter of the liposomes was determined by dynamic light scattering by means of a Malvern ZS Nanosizer (Malvern Instrumentation), while the efficiency of incorporation of ubiquinone or menaquinone into the liposomes was assessed by analytical HPLC-UV. Liposome suspensions typically contain 0.3-0.6Â mM of CoQ10 or vitamin K2. Mitochondria-targeted CoQ10 (MitoQ) and relative control compound Decyl-TPP (D-TPP) were synthetized as previously reported (<xref rid="bib36" ref-type="bibr">Murphy and Smith, 2007</xref>) and dissolved in DMSO at appropriate working concentrations. Embryos were injected at one-single cell stage with the indicated amount of MitoQ and D-TPP. Primary endothelial cells (HUAEC) were silenced for appropriate gene and treated for 24Â hr with MitoQ or D-TPP. Then, cells were analyzed by FACS analysis for mitochondrial membrane potential as previously described.</p>
            </sec>
            <sec id="dtbox1sec22">
              <title>Mitochondrial Membrane Potential (Ï) Analyses</title>
              <p>For mitochondria membrane potential analysis (Ï) 10<sup>5</sup> cells were incubated with JC-1 probe (Invitrogen, 4.5Â Î¼g/ml) for 15â at 37Â°C/ 5% CO<sub>2</sub>. Then cells were washed twice with PBS1X, trypsinzed, collected on prechilled tubes and immediately analyzed on FACSCalibur (Beckton-Dickinson). All procedures were performed in the dark. JC1 stock solution (5Â mg/ml) was diluted at intermediate stock solution (50Â Î¼g/ml) and vortex for several minutes to allow complete dissolution.</p>
            </sec>
            <sec id="dtbox1sec23">
              <title>Lipid Peroxidation Analyses</title>
              <p>Detection of lipid peroxidation was achieved in human primary endothelial cells (HUAEC) by measuring malondialdehyde-proteine (MDA) adducts with OxiSelect MDA Adduct ELISA Kit (CellBiolabs). 10<sup>6</sup> cells were trypsinized and centrifuged at room temperature for 800rpm /10â. Pellet was suspended with sterile PBS, supplemented with Complete Protease Inhibitor Cocktail (Roche) and lysed by micro-homogenization. Cell lysates were analyzed for protein content according to the Bradford assay and diluted as appropriate according to instructions. Enzyme reaction was stopped after 30â and OD450Â nm measurements were immediately read on Glomax Multi Detection System (Promega).</p>
            </sec>
            <sec id="dtbox1sec24">
              <title>Quantitative Real-Time PCR Analyses</title>
              <p>Total RNA was isolated with PureLink Micro-to-Midi Total RNA Purification System (Invitrogen) and cDNA was made with RT High Capacity kit (Applied Biosystems) according to the manufacturerâs protocol. Quantitative real-time RT-PCR on human cell samples was performed with ABI Prism 7300 real-time PCR System (Applied Biosystems) using Platinum Quantitative PCR SuperMix-UDG with ROX (Invitrogen). Following genes were analyzed with respective primers: human UBIAD1 (GeneBank accession number <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_013319.2">NM_013319.2</ext-link>; FW: 809-832; RW: 874-895) and probe #36 (Roche); human COQ2 (GeneBank accession number <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_015697.6">NM_015697.6</ext-link>; FW:937-959; RW: 1009-1030) and probe #37 (Roche). 18S rRNA was used as internal control.</p>
              <p>Zebrafish genes for qRT-PCR analysis were: <italic>gpx1a</italic> (GeneBank accession number: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_001007281.2">NM_001007281.2</ext-link>) and <italic>hmox1</italic> (GeneBank accession number: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NM_001127516">NM_001127516</ext-link>). Genes were selected as reported to be upregulated under oxidative stress conditions (<xref rid="bib70" ref-type="bibr">Malek etÂ al., 2004</xref>;) and qRT-PCR assay was performed by COGENTEC with following protocol: 5Â ng of cDNA was amplified (in triplicate) in a reaction volume of 15 uL containing the following reagents: 7.5ul of TaqMan PCR Mastermix 2x No UNG (Life Technologies, Foster City, CA), 0.75 ul of TaqMan Gene expression assay 20x (Life Technologies, Foster City, CA). Real-time PCR was carried out on the 7500 Sequence Detector System (Life Technologies), using a pre-PCR step of 10Â min at 95Â°C, followed by 40 cycles of 15Â s at 95Â°C and 60Â s at 60Â°C. Preparations with RNA template without reverse transcriptase were used as negative controls. Samples were amplified with following Q-PCR assay (Life Technologies, Foster City, CA): <italic>gpx1a</italic>: Dr03071768_m1; <italic>hmox1</italic>: Dr03434096_m1; <italic>Î²-actin</italic>: Dr03432610_m1. <italic>Î²-actin</italic> gene was included as control housekeeping gene.</p>
            </sec>
            <sec id="dtbox1sec25">
              <title>NOS Activity and NO Levels Analyses in Human Primary Endothelial Cells and in Zebrafish Embryos</title>
              <p>The NOS enzymatic activity was quantified using NOS Activity Assay Kit (Cayman Chemicals; No.781001). The assay is based on the biochemical conversion of L-Arginine to L-Citrulline by the eNOS and nNOS enzymes. Samples were human primary endothelial cells (HUAEC) or zebrafish embryos (nÂ = 100) at 72 hpf. Human primary endothelial cells (6<sup>â</sup>10<sup>6</sup>) were suspended with short treatment of trypsin and washed twice with PBS 1X. Cells were then centrifuged at 800Â rpm for 10Â min and suspended with 100Â Î¼l of Homogenization Buffer (Tris-HCl [pH 7.4]; 10Â mM EDTA, 10Â mM EGTA), microhomogenizated and sonicated. Samples lysates were centrifuged at 13,000Â rpm for 10Â min at 4Â°C. The supernatant was separated from pellet and quantified for proteins. Samples (50Â Î¼g) were incubated with a reaction mix containing 25Â mM Tris-HCl [pH 7.4], 1Â mM NADPH (Sigma, N1630), 0.6Â mM calcium cloride, 0.1Â Î¼M calmodulin, 3Â Î¼M tetrahydrobiopterin (BH4), 1Â Î¼M flavin adenine mononucleotide, 1Â Î¼M flavin adenine mononucleotide and [<sup>3</sup>H]-Arginine monohydrocloride (1 mCi/ml; Perkin Elmer, NET1123001MC). Samples were incubated at 37Â°C for 15Â min and stopped by adding 400Â Î¼l of stop-buffer. [<sup>3</sup>H]-Arginine was separated from [<sup>3</sup>H]-Citrulline by passing samples through the equilibrated resin provided by the kit. Radioactivity was quantitated by liquid scintillation counting. Activities were calculated on percentage of Citrulline formed in the reaction in relation to total possible counts and expressed as arbitrary parameter (percentage of activity to control sample).</p>
              <p>Live <italic>Tg(kdrl:mCherry)</italic><sup><italic>uto2</italic></sup> siblings<sup>s847</sup> (sib) and <italic>bar</italic>
<sup>s847</sup> (bar) mutant embryos were incubated at 56 hpf with 20Â Î¼M solution of DAF-2 DA (Calbiochem) in fish water, pH 7.0, in dark light at 28Â°C for 12Â hr. After incubation, embryos were washed twice in fish water, pH 7.0, and analyzed at 72 hpf at stereo fluorescence microscopy.</p>
            </sec>
            <sec id="dtbox1sec26">
              <title>Statistical Analyses</title>
              <p>All experiments were performed at least as three independent times for each conditions, and the error bars represent the mean of Â± the standard error of the mean, unless otherwise stated. Statistical significance was performed by a Studentâs test, as appropriate, and significance is reported in accordance with p value (<sup>â</sup>p â¤ 0.05, <sup>ââ</sup>p â¤ 0.01, <sup>âââ</sup>p â¤ 0.001).</p>
            </sec>
            <sec id="dtbox1sec27">
              <title>Microscopy and Image Analysis</title>
              <p>Images were acquired with TCSII SP5X confocal microscope, MZ16 FA stereomicroscope equipped with DCF300FY camera (Leica) or AZ100 stereomicroscope equipped with AxioCam MRm camera (Zeiss) and ApoTome AxioObserver Z1 (Zeiss). LAS AF and AxioVision software were used for analysis and image processing. Confocal acquisitions were analyzed for quantification of colocalization with ImageJ software applying Colocalization Finder PlugIn (<xref rid="bib17" ref-type="bibr">French etÂ al., 2008</xref>).</p>
            </sec>
            <sec id="dtbox1sec28">
              <title>Time-Lapse Experiments</title>
              <p>Siblings and <italic>barolo</italic> mutant embryos in Tg(kdrl:GFP)<sup>s843</sup> background were embedded in 0.5% low melting agarose in presence of PTU in 8-well microscopic chambers (Ibidi) with glass bottom. Embryos were imaged with a 20x dry objective lens (Leica N/A 0.5) with a confocal scanning microscope Leica TCSII SP5. z Stacks were acquired at 512Â Ã 512 resolution, scan speed of 400Â Hz, and 3 micron z step size. Images were taken every 20Â min for total movie duration of 12Â hr. Videos were processed with ImageJ software (<xref rid="bib65" ref-type="bibr">Abramoff etÂ al., 2004</xref>) and shown at 2 frames/s.</p>
            </sec>
          </boxed-text>
        </p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alp</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Channon</surname>
              <given-names>K.M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease</article-title>
          <source>Arterioscler. Thromb. Vasc. Biol.</source>
          <volume>24</volume>
          <year>2004</year>
          <fpage>413</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="pmid">14656731</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentinger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brismar</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The antioxidant role of coenzyme Q</article-title>
          <source>Mitochondrion</source>
          <volume>7</volume>
          <issue>Suppl</issue>
          <year>2007</year>
          <fpage>S41</fpage>
          <lpage>S50</lpage>
          <pub-id pub-id-type="pmid">17482888</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentinger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tekle</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brismar</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chojnacki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Swiezewska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of coenzyme Q synthesis</article-title>
          <source>Biofactors</source>
          <volume>32</volume>
          <year>2008</year>
          <fpage>99</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">19096105</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentinger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tekle</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Qâbiosynthesis and functions</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>396</volume>
          <year>2010</year>
          <fpage>74</fpage>
          <lpage>79</lpage>
          <pub-id pub-id-type="pmid">20494114</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Browning</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Chatterjee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>A.B.</given-names>
            </name>
          </person-group>
          <article-title>Stop the flow: a paradigm for cell signaling mediated by reactive oxygen species in the pulmonary endothelium</article-title>
          <source>Annu. Rev. Physiol.</source>
          <volume>74</volume>
          <year>2012</year>
          <fpage>403</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">22077215</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chew</surname>
              <given-names>G.T.</given-names>
            </name>
            <name>
              <surname>Watts</surname>
              <given-names>G.F.</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the ârecoupling hypothesisâ</article-title>
          <source>QJM</source>
          <volume>97</volume>
          <year>2004</year>
          <fpage>537</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">15256611</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Colavitti</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Pani</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bedogni</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Anzevino</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Borrello</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Waltenberger</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Galeotti</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>3101</fpage>
          <lpage>3108</lpage>
          <pub-id pub-id-type="pmid">11719508</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crane</surname>
              <given-names>F.L.</given-names>
            </name>
          </person-group>
          <article-title>Biochemical functions of coenzyme Q10</article-title>
          <source>J. Am. Coll. Nutr.</source>
          <volume>20</volume>
          <year>2001</year>
          <fpage>591</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="pmid">11771674</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crane</surname>
              <given-names>F.L.</given-names>
            </name>
          </person-group>
          <article-title>Discovery of ubiquinone (coenzyme Q) and an overview of function</article-title>
          <source>Mitochondrion</source>
          <volume>7</volume>
          <issue>Suppl</issue>
          <year>2007</year>
          <fpage>S2</fpage>
          <lpage>S7</lpage>
          <pub-id pub-id-type="pmid">17446142</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Crane</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Morre</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <chapter-title>Evidence for coenzyme Q function in Golgi membranes</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Folkers</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamamura</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <source>Biomedical and Clinical Aspects of Coenzyme Q</source>
          <year>1977</year>
          <publisher-name>Elsevier</publisher-name>
          <publisher-loc>Amsterdam</publisher-loc>
          <fpage>3</fpage>
          <lpage>14</lpage>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DâAutrÃ©aux</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Toledano</surname>
              <given-names>M.B.</given-names>
            </name>
          </person-group>
          <article-title>ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>8</volume>
          <year>2007</year>
          <fpage>813</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="pmid">17848967</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Bitner-Glindzicz</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meunier</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Costello</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hargreaves</surname>
              <given-names>I.P.</given-names>
            </name>
            <name>
              <surname>LÃ³pez</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Quinzii</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Sadowski</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>84</volume>
          <year>2009</year>
          <fpage>558</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">19375058</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finkel</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Oxidant signals and oxidative stress</article-title>
          <source>Curr. Opin. Cell Biol.</source>
          <volume>15</volume>
          <year>2003</year>
          <fpage>247</fpage>
          <lpage>254</lpage>
          <pub-id pub-id-type="pmid">12648682</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finkel</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Holbrook</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Oxidants, oxidative stress and the biology of ageing</article-title>
          <source>Nature</source>
          <volume>408</volume>
          <year>2000</year>
          <fpage>239</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">11089981</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forsgren</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Attersand</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lake</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>GrÃ¼nler</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Swiezewska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Climent</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Isolation and functional expression of human COQ2, a gene encoding a polyprenyl transferase involved in the synthesis of CoQ</article-title>
          <source>Biochem. J.</source>
          <volume>382</volume>
          <year>2004</year>
          <fpage>519</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="pmid">15153069</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>FÃ¶rstermann</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Sessa</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide synthases: regulation and function</article-title>
          <source>Eur. Heart J.</source>
          <volume>33</volume>
          <year>2012</year>
          <fpage>829</fpage>
          <lpage>837</lpage>
          <comment>837aâ837d</comment>
          <pub-id pub-id-type="pmid">21890489</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>French</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Swarup</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Pridmore</surname>
              <given-names>T.P.</given-names>
            </name>
          </person-group>
          <article-title>Colocalization of fluorescent markers in confocal microscope images of plant cells</article-title>
          <source>Nat. Protoc.</source>
          <volume>3</volume>
          <year>2008</year>
          <fpage>619</fpage>
          <lpage>628</lpage>
          <pub-id pub-id-type="pmid">18388944</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fritsche</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Schwerte</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Pelster</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide and vascular reactivity in developing zebrafish, Danio rerio</article-title>
          <source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source>
          <volume>279</volume>
          <year>2000</year>
          <fpage>R2200</fpage>
          <lpage>R2207</lpage>
          <pub-id pub-id-type="pmid">11080086</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fulton</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fontana</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Sowa</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gratton</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>K.X.</given-names>
            </name>
            <name>
              <surname>Michell</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kemp</surname>
              <given-names>B.E.</given-names>
            </name>
            <name>
              <surname>Rodman</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Sessa</surname>
              <given-names>W.C.</given-names>
            </name>
          </person-group>
          <article-title>Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme</article-title>
          <source>J.Â Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>4277</fpage>
          <lpage>4284</lpage>
          <pub-id pub-id-type="pmid">11729179</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giordano</surname>
              <given-names>F.J.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen, oxidative stress, hypoxia, and heart failure</article-title>
          <source>J.Â Clin. Invest.</source>
          <volume>115</volume>
          <year>2005</year>
          <fpage>500</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">15765131</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hare</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>NO/redox disequilibrium in the failing heart and cardiovascular system</article-title>
          <source>J. Clin. Invest.</source>
          <volume>115</volume>
          <year>2005</year>
          <fpage>509</fpage>
          <lpage>517</lpage>
          <pub-id pub-id-type="pmid">15765132</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heeringa</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Chernin</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Chaki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Sloan</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>L.X.</given-names>
            </name>
            <name>
              <surname>Salviati</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hurd</surname>
              <given-names>T.W.</given-names>
            </name>
            <name>
              <surname>Vega-Warner</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness</article-title>
          <source>J.Â Clin. Invest.</source>
          <volume>121</volume>
          <year>2011</year>
          <fpage>2013</fpage>
          <lpage>2024</lpage>
          <pub-id pub-id-type="pmid">21540551</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hess</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>S.O.</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Protein S-nitrosylation: purview and parameters</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>6</volume>
          <year>2005</year>
          <fpage>150</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="pmid">15688001</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jin</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Santoro</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Frantsve</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jungblut</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Beis</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>DâAmico</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Ober</surname>
              <given-names>E.A.</given-names>
            </name>
          </person-group>
          <article-title>A transgene-assisted genetic screen identifies essential regulators of vascular development in vertebrate embryos</article-title>
          <source>Dev. Biol.</source>
          <volume>307</volume>
          <year>2007</year>
          <fpage>29</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">17531218</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Jonassen</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>C.F.</given-names>
            </name>
          </person-group>
          <chapter-title>Genetic Analysis of Coenzyme Q Biosynthesis</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Kagan</surname>
              <given-names>V.E.</given-names>
            </name>
            <name>
              <surname>Quinn</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <source>Coenzyme Q: Molecular Mechanisms in Health and Disease</source>
          <year>2000</year>
          <publisher-name>CRC Press LLC</publisher-name>
          <publisher-loc>Boca Raton, FL</publisher-loc>
          <fpage>185</fpage>
          <lpage>208</lpage>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalen</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Appelkvist</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis of ubiquinone in rat liver</article-title>
          <source>Acta Chem. Scand. A</source>
          <volume>41</volume>
          <year>1987</year>
          <fpage>70</fpage>
          <lpage>72</lpage>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>KalÃ©n</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Appelkvist</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Chojnacki</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver</article-title>
          <source>J. Biol. Chem.</source>
          <volume>265</volume>
          <year>1990</year>
          <fpage>1158</fpage>
          <lpage>1164</lpage>
          <pub-id pub-id-type="pmid">2295606</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kaur</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Devi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mohan</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>124</volume>
          <year>2009</year>
          <fpage>259</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="pmid">19638284</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuster</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>HÃ¤uselmann</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Rosc-SchlÃ¼ter</surname>
              <given-names>B.I.</given-names>
            </name>
            <name>
              <surname>Lorenz</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Pfister</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Reactive oxygen/nitrogen species and the myocardial cell homeostasis: an ambiguous relationship</article-title>
          <source>Antioxid. Redox Signal.</source>
          <volume>13</volume>
          <year>2010</year>
          <fpage>1899</fpage>
          <lpage>1910</lpage>
          <pub-id pub-id-type="pmid">20698753</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lander</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Milbank</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Tauras</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Hajjar</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Hempstead</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Kraemer</surname>
              <given-names>R.T.</given-names>
            </name>
            <name>
              <surname>Mirza</surname>
              <given-names>U.A.</given-names>
            </name>
            <name>
              <surname>Chait</surname>
              <given-names>B.T.</given-names>
            </name>
            <name>
              <surname>Burk</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Redox regulation of cell signaling</article-title>
          <source>Nature</source>
          <volume>30</volume>
          <year>1996</year>
          <fpage>380</fpage>
          <lpage>381</lpage>
          <pub-id pub-id-type="pmid">8632794</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Sebzda</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Bertozzi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mericko</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Stadtfeld</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Klf2 is an essential regulator of vascular hemodynamic forces inÂ vivo</article-title>
          <source>Dev. Cell</source>
          <volume>11</volume>
          <year>2006</year>
          <fpage>845</fpage>
          <lpage>857</lpage>
          <pub-id pub-id-type="pmid">17141159</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fiskum</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Generation of reactive oxygen species by the mitochondrial electron transport chain</article-title>
          <source>J. Neurochem.</source>
          <volume>80</volume>
          <year>2002</year>
          <fpage>780</fpage>
          <lpage>787</lpage>
          <pub-id pub-id-type="pmid">11948241</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dui</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Jiao</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Drosophila sbo regulates lifespan through its function in the synthesis of coenzyme Q inÂ vivo</article-title>
          <source>J. Genet. Genomics</source>
          <volume>38</volume>
          <year>2011</year>
          <fpage>225</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">21703546</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matlung</surname>
              <given-names>H.L.</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>VanBavel</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Shear stress, reactive oxygen species, and arterial structure and function</article-title>
          <source>Antioxid. Redox Signal.</source>
          <volume>11</volume>
          <year>2009</year>
          <fpage>1699</fpage>
          <lpage>1709</lpage>
          <pub-id pub-id-type="pmid">19186981</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism</article-title>
          <source>Nature</source>
          <volume>191</volume>
          <year>1961</year>
          <fpage>144</fpage>
          <lpage>148</lpage>
          <pub-id pub-id-type="pmid">13771349</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>R.A.J.</given-names>
            </name>
          </person-group>
          <article-title>Targeting antioxidants to mitochondria by conjugation to lipophilic cations</article-title>
          <source>Annu. Rev. Pharmacol. Toxicol.</source>
          <volume>47</volume>
          <year>2007</year>
          <fpage>629</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">17014364</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakagawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hirota</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Yuge</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Uchino</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okuda</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Shimomura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Suhara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Okano</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme</article-title>
          <source>Nature</source>
          <volume>468</volume>
          <year>2010</year>
          <fpage>117</fpage>
          <lpage>121</lpage>
          <pub-id pub-id-type="pmid">20953171</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Navas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Villalba</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>de Cabo</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>The importance of plasma membrane coenzyme Q in aging and stress responses</article-title>
          <source>Mitochondrion</source>
          <volume>7</volume>
          <issue>Suppl</issue>
          <year>2007</year>
          <fpage>S34</fpage>
          <lpage>S40</lpage>
          <pub-id pub-id-type="pmid">17482527</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nickerson</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Kostiha</surname>
              <given-names>B.N.</given-names>
            </name>
            <name>
              <surname>Brandt</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Fredericks</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>K.P.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>F.S.</given-names>
            </name>
            <name>
              <surname>Gold</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chodosh</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>UBIAD1 mutation alters a mitochondrial prenyltransferase to cause Schnyder corneal dystrophy</article-title>
          <source>PLoS ONE</source>
          <volume>5</volume>
          <year>2010</year>
          <fpage>e10760</fpage>
          <pub-id pub-id-type="pmid">20505825</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nicoli</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Standley</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hurlstone</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Fogarty</surname>
              <given-names>K.E.</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>N.D.</given-names>
            </name>
          </person-group>
          <article-title>MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis</article-title>
          <source>Nature</source>
          <volume>464</volume>
          <year>2010</year>
          <fpage>1196</fpage>
          <lpage>1200</lpage>
          <pub-id pub-id-type="pmid">20364122</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>T.E.</given-names>
            </name>
            <name>
              <surname>Goessling</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Peeters</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ceol</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lord</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cutting</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Hematopoietic stem cell development is dependent on blood flow</article-title>
          <source>Cell</source>
          <volume>137</volume>
          <year>2009</year>
          <fpage>736</fpage>
          <lpage>748</lpage>
          <pub-id pub-id-type="pmid">19450519</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>OâNeill</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Reddy</surname>
              <given-names>A.B.</given-names>
            </name>
          </person-group>
          <article-title>Circadian clocks in human red blood cells</article-title>
          <source>Nature</source>
          <volume>469</volume>
          <year>2011</year>
          <fpage>498</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="pmid">21270888</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Orr</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>DubÃ©</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Marcadier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Federico</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Seamone</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dubord</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Holland</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the UBIAD1 gene, encoding a potential prenyltransferase, are causal for Schnyder crystalline corneal dystrophy</article-title>
          <source>PLoS ONE</source>
          <volume>2</volume>
          <year>2007</year>
          <fpage>e685</fpage>
          <pub-id pub-id-type="pmid">17668063</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelster</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Grillitsch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schwerte</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>NO as a mediator during the early development of the cardiovascular system in the zebrafish</article-title>
          <source>Comp. Biochem. Physiol. A Mol. Integr. Physiol.</source>
          <volume>142</volume>
          <year>2005</year>
          <fpage>215</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">15958285</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pepe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marasco</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Sheeran</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Krum</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Rosenfeldt</surname>
              <given-names>F.L.</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q10 in cardiovascular disease</article-title>
          <source>Mitochondrion</source>
          <volume>7</volume>
          <issue>Suppl</issue>
          <year>2007</year>
          <fpage>S154</fpage>
          <lpage>S167</lpage>
          <pub-id pub-id-type="pmid">17485243</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinzii</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Naini</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Salviati</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Trevisson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Dimauro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>78</volume>
          <year>2006</year>
          <fpage>345</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">16400613</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rigoulet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yoboue</surname>
              <given-names>E.D.</given-names>
            </name>
            <name>
              <surname>Devin</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling</article-title>
          <source>Antioxid. Redox Signal.</source>
          <volume>14</volume>
          <year>2011</year>
          <fpage>459</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="pmid">20649461</pub-id>
        </element-citation>
      </ref>
      <ref id="bib48">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salviati</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sacconi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Murer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zacchello</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Franceschini</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Laverda</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Quinzii</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Angelini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition</article-title>
          <source>Neurology</source>
          <volume>65</volume>
          <year>2005</year>
          <fpage>606</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="pmid">16116126</pub-id>
        </element-citation>
      </ref>
      <ref id="bib49">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santoro</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Samuel</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Stainier</surname>
              <given-names>D.Y.</given-names>
            </name>
          </person-group>
          <article-title>Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis</article-title>
          <source>Nat. Genet.</source>
          <volume>39</volume>
          <year>2007</year>
          <fpage>1397</fpage>
          <lpage>1402</lpage>
          <pub-id pub-id-type="pmid">17934460</pub-id>
        </element-citation>
      </ref>
      <ref id="bib50">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>T.S.</given-names>
            </name>
            <name>
              <surname>Alp</surname>
              <given-names>N.J.</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease</article-title>
          <source>Clin. Sci.</source>
          <volume>113</volume>
          <year>2007</year>
          <fpage>47</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">17555404</pub-id>
        </element-citation>
      </ref>
      <ref id="bib51">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Searles</surname>
              <given-names>C.D.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression</article-title>
          <source>Am. J. Physiol. Cell Physiol.</source>
          <volume>291</volume>
          <year>2006</year>
          <fpage>C803</fpage>
          <lpage>C816</lpage>
          <pub-id pub-id-type="pmid">16738003</pub-id>
        </element-citation>
      </ref>
      <ref id="bib52">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sehnert</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Huq</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stainier</surname>
              <given-names>D.Y.</given-names>
            </name>
          </person-group>
          <article-title>Cardiac troponin T is essential in sarcomere assembly and cardiac contractility</article-title>
          <source>Nat. Genet.</source>
          <volume>31</volume>
          <year>2002</year>
          <fpage>106</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">11967535</pub-id>
        </element-citation>
      </ref>
      <ref id="bib53">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stamler</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Lamas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>F.C.</given-names>
            </name>
          </person-group>
          <article-title>Nitrosylation. the prototypic redox-based signaling mechanism</article-title>
          <source>Cell</source>
          <volume>106</volume>
          <year>2001</year>
          <fpage>675</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="pmid">11572774</pub-id>
        </element-citation>
      </ref>
      <ref id="bib54">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuehr</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Oxygen reduction by nitric-oxide synthases</article-title>
          <source>J. Biol. Chem.</source>
          <volume>276</volume>
          <year>2001</year>
          <fpage>14533</fpage>
          <lpage>14536</lpage>
          <pub-id pub-id-type="pmid">11279231</pub-id>
        </element-citation>
      </ref>
      <ref id="bib55">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Protein S-nitrosylation and cardioprotection</article-title>
          <source>Circ. Res.</source>
          <volume>106</volume>
          <year>2010</year>
          <fpage>285</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">20133913</pub-id>
        </element-citation>
      </ref>
      <ref id="bib56">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swiezewska</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ernster</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis of ubiquinone and plastoquinone in the endoplasmic reticulum-Golgi membranes of spinach leaves</article-title>
          <source>J. Biol. Chem.</source>
          <volume>268</volume>
          <year>1993</year>
          <fpage>1494</fpage>
          <lpage>1499</lpage>
          <pub-id pub-id-type="pmid">8419349</pub-id>
        </element-citation>
      </ref>
      <ref id="bib57">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trevisson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Navas</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Salviati</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Coenzyme Q deficiency in muscle</article-title>
          <source>Curr. Opin. Neurol.</source>
          <volume>24</volume>
          <year>2011</year>
          <fpage>449</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">21844807</pub-id>
        </element-citation>
      </ref>
      <ref id="bib58">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Kao</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Chiou</surname>
              <given-names>G.Y.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y.P.</given-names>
            </name>
          </person-group>
          <article-title>A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways</article-title>
          <source>J. Nutr. Biochem.</source>
          <volume>23</volume>
          <year>2012</year>
          <fpage>458</fpage>
          <lpage>468</lpage>
          <pub-id pub-id-type="pmid">21684136</pub-id>
        </element-citation>
      </ref>
      <ref id="bib59">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turunen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Olsson</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dallner</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Metabolism and function of coenzyme Q</article-title>
          <source>Biochim. Biophys. Acta</source>
          <volume>1660</volume>
          <year>2004</year>
          <fpage>171</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">14757233</pub-id>
        </element-citation>
      </ref>
      <ref id="bib60">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ushio-Fukai</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Localizing NADPH oxidase-derived ROS</article-title>
          <source>Sci. STKE</source>
          <volume>2006</volume>
          <year>2006</year>
          <fpage>re8</fpage>
          <pub-id pub-id-type="pmid">16926363</pub-id>
        </element-citation>
      </ref>
      <ref id="bib61">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Patient</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>A blood flow-dependent klf2a-NO signaling cascade is required for stabilization of hematopoietic stem cell programming in zebrafish embryos</article-title>
          <source>Blood</source>
          <volume>118</volume>
          <year>2011</year>
          <fpage>4102</fpage>
          <lpage>4110</lpage>
          <pub-id pub-id-type="pmid">21849483</pub-id>
        </element-citation>
      </ref>
      <ref id="bib62">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Kruth</surname>
              <given-names>H.S.</given-names>
            </name>
            <name>
              <surname>Kuivaniemi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tromp</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Winters</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Lisch</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Henn</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Denninger</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the UBIAD1 gene on chromosome short arm 1, region 36, cause Schnyder crystalline corneal dystrophy</article-title>
          <source>Invest. Ophthalmol. Vis. Sci.</source>
          <volume>48</volume>
          <year>2007</year>
          <fpage>5007</fpage>
          <lpage>5012</lpage>
          <pub-id pub-id-type="pmid">17962451</pub-id>
        </element-citation>
      </ref>
      <ref id="bib63">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Werner</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>GTPases and reactive oxygen species: switches for killing and signaling</article-title>
          <source>J. Cell Sci.</source>
          <volume>117</volume>
          <year>2004</year>
          <fpage>143</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">14676270</pub-id>
        </element-citation>
      </ref>
      <ref id="bib64">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yellore</surname>
              <given-names>V.S.</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Bourla</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Rayner</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Sonmez</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Momi</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Sampat</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Gorin</surname>
              <given-names>M.B.</given-names>
            </name>
            <name>
              <surname>Aldave</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Identification of mutations in UBIAD1 following exclusion of coding mutations in the chromosome 1p36 locus for Schnyder crystalline corneal dystrophy</article-title>
          <source>Mol. Vis.</source>
          <volume>13</volume>
          <year>2007</year>
          <fpage>1777</fpage>
          <lpage>1782</lpage>
          <pub-id pub-id-type="pmid">17960116</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Supplemental References</title>
      <ref id="bib65">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abramoff</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Magalhaes</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Ram</surname>
              <given-names>S.J.</given-names>
            </name>
          </person-group>
          <article-title>Image Processing with ImageJ</article-title>
          <source>Biophotonics International.</source>
          <volume>7</volume>
          <year>2004</year>
          <fpage>36</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="bib66">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Covassin</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Amigo</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Teplyuk</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Straubhaar</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>N.D.</given-names>
            </name>
          </person-group>
          <article-title>Global analysis of hematopoietic and vascular endothelial gene expression by tissue specific microarray profiling in zebrafish</article-title>
          <source>Dev. Biol.</source>
          <volume>299</volume>
          <year>2006</year>
          <fpage>551</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="pmid">16999953</pub-id>
        </element-citation>
      </ref>
      <ref id="bib67">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>D.A.</given-names>
            </name>
          </person-group>
          <article-title>Cell-autonomous action of zebrafish spt-1 mutation in specific mesodermal precursors</article-title>
          <source>Nature</source>
          <volume>348</volume>
          <year>1990</year>
          <fpage>728</fpage>
          <lpage>730</lpage>
          <pub-id pub-id-type="pmid">2259382</pub-id>
        </element-citation>
      </ref>
      <ref id="bib68">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwan</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Grabher</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mangum</surname>
              <given-names>B.D.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Parant</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Yost</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Kanki</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>C.-B.</given-names>
            </name>
          </person-group>
          <article-title>The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title>
          <source>Dev. Dyn.</source>
          <volume>236</volume>
          <year>2007</year>
          <fpage>3088</fpage>
          <lpage>3099</lpage>
          <pub-id pub-id-type="pmid">17937395</pub-id>
        </element-citation>
      </ref>
      <ref id="bib69">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindner</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>One-step separation of endocytic organelles, Golgi/trans-Golgi network and plasma membrane by density gradient electrophoresis</article-title>
          <source>Electrophoresis</source>
          <volume>22</volume>
          <year>2001</year>
          <fpage>386</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">11258743</pub-id>
        </element-citation>
      </ref>
      <ref id="bib70">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Malek</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Sajadi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Abraham</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Grundy</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Gerhard</surname>
              <given-names>G.S.</given-names>
            </name>
          </person-group>
          <article-title>The effects of temperature reduction on gene expression and oxidative stress in skeletal muscle from adult zebrafish</article-title>
          <source>Comp. Biochem. Physiol. C Toxicol. Pharmacol.</source>
          <volume>138</volume>
          <year>2004</year>
          <fpage>363</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">15533794</pub-id>
        </element-citation>
      </ref>
      <ref id="bib71">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Michelmore</surname>
              <given-names>R.W.</given-names>
            </name>
            <name>
              <surname>Paran</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kesseli</surname>
              <given-names>R.V.</given-names>
            </name>
          </person-group>
          <article-title>Identification of markers linked to disease-resistance genes by bulked segregant analysis: a rapid method to detect markers in specific genomic regions by using segregating populations</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>88</volume>
          <year>1991</year>
          <fpage>9828</fpage>
          <lpage>9832</lpage>
          <pub-id pub-id-type="pmid">1682921</pub-id>
        </element-citation>
      </ref>
      <ref id="bib72">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Rice</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>J.G.</given-names>
            </name>
          </person-group>
          <chapter-title>Subcellular fraction of mitochondria</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Graham</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Rickwood</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <source>subcellular Fractionation: A practical approach</source>
          <year>1997</year>
          <publisher-name>IRL Press</publisher-name>
          <publisher-loc>Oxford</publisher-loc>
          <fpage>107</fpage>
          <lpage>142</lpage>
        </element-citation>
      </ref>
      <ref id="bib73">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruiz-JimÃ©nez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Priego-Capote</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mata-Granados</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Quesada</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Luque de Castro</surname>
              <given-names>M.D.</given-names>
            </name>
          </person-group>
          <article-title>Determination of the ubiquinol-10 and ubiquinone-10 (coenzyme Q10) in human serum by liquid chromatography tandem mass spectrometry to evaluate the oxidative stress</article-title>
          <source>J. Chromatogr. A</source>
          <volume>1175</volume>
          <year>2007</year>
          <fpage>242</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">17996879</pub-id>
        </element-citation>
      </ref>
      <ref id="bib74">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santoro</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Pesce</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stainier</surname>
              <given-names>D.Y.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of vascular mural cells during zebrafish development</article-title>
          <source>Mech. Dev.</source>
          <volume>126</volume>
          <year>2009</year>
          <fpage>638</fpage>
          <lpage>649</lpage>
          <pub-id pub-id-type="pmid">19539756</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app2" sec-type="supplementary-material">
      <title>Supplemental Information</title>
      <p>
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Table S1</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Movie S1. Time-Lapse Movies Showing Normal Endothelial Development in <italic>bar</italic> Mutant Embryos between 32 and 48 hpf, Related to FigureÂ 1</title>
            <p>Wild-type siblings embryos were analyzed for endothelial cell development at the level of the trunk vasculature from 32 to 48 hpf. Movies are z stack time-lapse of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> siblings between 32 and 48 hpf is shown.</p>
          </caption>
          <media xlink:href="mmc2.avi"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc3">
          <caption>
            <title>Movie S2. Time-Lapse Movies Show that Endothelial Disintegration in Bar Mutant Embryos Starts between 32 and 48 hpf, Related to FigureÂ 1</title>
            <p><italic>barolo</italic> (<italic>bar</italic>) mutant embryos were analyzed for endothelial cell disintegration at the level of the trunk vasculature. z Stack time-lapse movies of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>barolo</italic><sup>t31131</sup> (bar) mutants between 32 and 48 show vascular integrity disintegration in the trunk vasculature (arrows) starting at 32 hpf. Endothelial cell regression is observed throughout the vascular network starting in intersegmental vessels (Se) and, later, also in dorsal aorta (DA).</p>
          </caption>
          <media xlink:href="mmc3.avi"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc4">
          <caption>
            <title>Movie S3. Time-Lapse Movies Showing Normal Endothelial Development in <italic>bar</italic> Mutant Embryos between 48 and 60 hpf, Related to FigureÂ 1</title>
            <p>Wild-type siblings embryos were analyzed for endothelial cell development at the level of the trunk vasculature. z Stack time-lapse movie of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> siblings between 48 and 60 hpf is shown.</p>
          </caption>
          <media xlink:href="mmc4.avi"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc5">
          <caption>
            <title>Movie S4. Time-Lapse Movies Show that Endothelial Disintegration in <italic>bar</italic> Mutant Embryos between 48 and 60 hpf, Related to FigureÂ 1</title>
            <p><italic>barolo</italic> (<italic>bar</italic>) mutant embryos were analyzed for endothelial cell disintegration at the level of the trunk vasculature. z Stack time-lapse movies of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>barolo</italic><sup>t31131</sup> (bar) mutants between 48 and 60 hpf show vascular integrity disintegration in the trunk vasculature (arrows) progressively through 60 hpf. Endothelial cell regression is observed throughout the vascular network starting in intersegmental vessels (Se) and later also in dorsal aorta (DA).</p>
          </caption>
          <media xlink:href="mmc5.avi"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc6">
          <caption>
            <title>Document S2. Article plus Supplemental Information</title>
          </caption>
          <media xlink:href="mmc6.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Federica Logrand, Marco Vincenti, Annalisa Camporeale, and Ellen Jane Corcoran for technical assistances as well as Pier Paolo Pandolfi, Guido Serini, Massimiliano Mazzone, Franz Enzmann and Silvio Aime for discussion, technical support and reagents. This work was supported by a HFSP Career Developmental Award (MMS), Marie Curie Action IRG 247852 (MMS), Telethon GGP10185(MMS), AIRC-MFAG 8911(MMS) and FP7-NMP-2007-214539 (JB). VM and MMS planned and discussed the whole project. RP positionally cloned the t31131 allele in JBâs lab. Independently, MMS identified the s847 allele in DYRSâ lab. RP performed ubiad1 expression analyses and cell transplantation experiments in zebrafish. MPM provided the MitoQ. ET produced the Ubiad1 MAb. VM and MMS performed all other experiments together with VC, GD, CM, EDL and LS. MMS wrote the manuscript and all authors commented on it. The authors declare no conflict of interests.</p>
    </ack>
    <fn-group>
      <fn id="app1" fn-type="supplementary-material">
        <p>Supplemental Information includes Extended Experimental Procedures, six figures, one table, and four movies and can be found with this article online at <ext-link ext-link-type="doi" xlink:href="10.1016/j.cell.2013.01.013">http://dx.doi.org/10.1016/j.cell.2013.01.013</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
  <floats-group>
    <fig id="fig1">
      <label>FigureÂ 1</label>
      <caption>
        <p>Loss of Ubiad1 Induces Cardiovascular Failure in Zebrafish Embryos by Increasing Oxidative Stress</p>
        <p>(A and B) Siblings (sib) and <italic>barolo</italic><sup>t31131</sup> (<italic>bar</italic>) mutant embryos at 65 hpf. (A) Vascular hemorrhages (asterisks) and heart failure (arrowhead) in <italic>bar</italic>. (B)Â <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> show vascular integrity defects (arrows) and collapsed endocardium (arrowhead). Scale bar, 300Â Î¼m.</p>
        <p>(C) <italic>Tg(Fli1a:GFP)</italic><sup><italic>y1</italic></sup><italic>bar</italic> show severe loss of cranial network vasculature and fragmented endothelium (arrow) at 65 hpf.</p>
        <p>(D) Confocal images of trunk vasculature of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> report loss of ECs at the level of Se, DA (arrows), and PCV. Scale bar, 50Â Î¼m.</p>
        <p>(E) NADP<sup>+</sup>/NADPH ratio at 60 hpf. Increased ratio is indicative of oxidative stress state.</p>
        <p>(F) Real-time PCR analysis show upregulation of the antioxidant genes <italic>glutathione peroxidase1a</italic> (<italic>gpx1a</italic>) and <italic>heme-oxigenase1</italic> (<italic>hmox1</italic>) in <italic>bar</italic> at 56 hpf. Data are means Â± SD.</p>
        <p>(G) Quantification of oxidative stress level in ECs derived from <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> embryos at 56 hpf.</p>
        <p>(H) Immunofluorescence analyses for S-nitroso-cysteine (SNO-Cys, red) and DNA (blue) in <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> and <italic>sib</italic> embryos at 60 hpf. Upper left: heart transverse sections; upper right: quantification of SNO-Cys positive cells. Lower left: trunk vasculature transverse sections; lower right: quantification of SNO-Cys positive cells. Scale bar, 75Â Î¼m. Specific SNO-Cys signals were also detectable in pronephros and myocardium of <italic>bar</italic> (arrowhead).</p>
        <p>(I) Immunofluorescence analyses for 8-hydroxy-2â²deoxyguanosine (8OHdG, red) and DNA (blue) in <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> and sib at 56 hpf. Upper left: heart transverse sections; upper right: quantification of 8OHdG positive cells. Scale bars, 50Â Î¼m. Lower left: trunk vasculature transverse sections; lower right; quantification of 8OHdG positive. Scale bar, 20Â Î¼m. <italic>bar</italic> show specific 8OHdG staining in endocardial and endothelial cells (arrows) and myocardium (arrowhead).</p>
        <p>(L) TUNEL-positive (red) cells show apoptosis in endocardium and endothelium (arrows). Upper left: heart transverse sections of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic><sup>s847</sup> and sib; upper right: quantification of TUNEL-positive cells. Lower left: transverse sections of trunk vasculature; lower right: quantification of positive cells in DA and PCV. Scale bars, 20Â Î¼m.</p>
        <p>(M) Genetic map of the zebrafish <italic>barolo</italic> locus. The SSLP markers (z22307) was used to identify the âzero recombinantâ region by analysis of 987 diploid mutants.</p>
        <p>(N) Schematic representation of zebrafish Ubiad1. UbiA:UbiA domain.</p>
        <p>(O) Western blot analysis of protein extracts from <italic>bar</italic><sup>s847</sup> and <italic>bar</italic><sup>t31131</sup> and respective siblings at 72 hpf.</p>
        <p>(P) Embryos from <italic>bar</italic><sup>s847</sup> and <italic>bar</italic><sup>t31131</sup> heterozygote intercrosses were injected with mRNA encoding for wild-type <italic>ubiad1</italic> mRNA, <italic>ubiad1</italic><sup><italic>L62Q</italic></sup> or fluorescent protein <italic>cherry</italic> (ctrl). <italic>bar</italic><sup>s847</sup> as well as <italic>bar</italic><sup>t31131</sup> were not rescued by microinjection of <italic>ubiad1</italic><sup><italic>L62Q</italic></sup> mRNA.</p>
        <p>A, atrium; V, ventricle; DA, dorsal aorta; PCV, posterior cardinal vein; BuA bulbus arteriosus; PD, pronephric ducts; E, endocardium; M myocardium. All data are means Â± SEM. <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
        <p>See also <xref rid="figs1" ref-type="fig">FigureÂ S1</xref>, <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>, and <xref rid="mmc2" ref-type="supplementary-material">Movies S1</xref>, <xref rid="mmc3" ref-type="supplementary-material">S2</xref>, <xref rid="mmc4" ref-type="supplementary-material">S3</xref>, and <xref rid="mmc5" ref-type="supplementary-material">S4</xref>.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>FigureÂ 2</label>
      <caption>
        <p>Ubiad1 Is a Prenyltranferase Required for CoQ10 Biosynthesis in Vertebrates</p>
        <p>(A) Schematic representation of the <sup>13</sup>C-based metabolomic approach used to demonstrate that Ubiad1 is a 4-OH-benzoic acid-prenyltranferase enzyme. Coenzyme Q10 (CoQ10) biosynthesis starts with formation of a hydroxy-benzoic acid head group (4-OH-benzoic acid) and a lipophilic polyisoprenoid tail (polyprenyl-PP). The aromatic precursor of the benzoquinone ring (4-OH-benzoic acid) derives from tyrosine. Synthesis of the polyisoprenoid tail takes place in the cytoplasm starting from acetyl-CoA through the mevalonate pathway (which is shared with the cholesterol and dolichol biosynthetic pathways). The polyisoprenoid tail is assembled by polyprenyl diphosphate synthase, which is responsible for determining the number of isoprene units (designated as n). Next is the condensation of the polyisoprenoid chain with the benzoquinone ring to form the 4-hydroxy-3-polyprenyl benzoic acid intermediate (PPHB) by a 4-OH-benzoic-polyprenyl-tranferase (UbiA-containing enzyme). The subsequent reactions (O-methylations and C-methylations, hydroxylations and decarboxylations) modify the structure of the aromatic ring, but some of the enzymes involved are still unknown. Exogenous 4-OH-benzoic acid-<sup>13</sup>C<sub>6</sub> containing heavy carbon element (<sup>13</sup>C) is administered to embryos and cells so that de novo synthesis of PPHB and therefore CoQ10 can be monitored by HPLC-MS analyses. Loss of UbiA-containing enzymes (red) blocks the condensation of the polyisoprenoid chain with the benzoquinone ring and then formation of CoQ-<sup>13</sup>C<sub>6</sub>. <sup>13</sup>C<sub>6</sub>-labeled compounds used or detected in this work are shown in green.</p>
        <p>(B) High-resolution MS spectrum of lipid extracts from wild-type zebrafish embryos. The MS spectrum of the HPLC fraction containing CoQ10 reveals the analyte as [CoQ10-Na<sup>+</sup>] at <italic>m/z</italic>Â = 885.6751.</p>
        <p>(C) HPLC-MS analyses show that <italic>bar</italic> mutants are characterized by a reduced level of endogenous CoQ10 in comparison to their siblings.</p>
        <p>(D) Exogenous supplement of CoQ10, but not of VitaminK2, can efficiently rescue <italic>bar</italic> mutants. CoQ10<sup>F1</sup>; liposomal CoQ10 preparation 0.6Â mM; CoQ10<sup>F2</sup>, LiQsorb Liposomal CoQ10 Gel 0.6Â mM; COQ10 <sup>F3</sup>, SANOMIT nanoparticles CoQ10 liquid, 6.9Â mM; VitK; Liposomal Vitamin K2 0.3Â mM.</p>
        <p>(E and F) Levels of <sup>13</sup>C<sub>6</sub>-labeled CoQ10 (CoQ10-<sup>13</sup>C<sub>6</sub>) and <sup>13</sup>C<sub>6</sub>-labeled CoQ9 (CoQ9-<sup>13</sup>C<sub>6</sub>) are detected by HPLC-MS in <italic>bar</italic> mutants and siblings at 72 hpf. LossÂ of Ubiad1 expression protein significantly reduces de novo CoQ10-<sup>13</sup>C<sub>6</sub> synthesis by 78% (E) and de novo CoQ9-<sup>13</sup>C<sub>6</sub> synthesis by 66.5% (F). All data are means Â± SEM. <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
        <p>See also <xref rid="figs2" ref-type="fig">FigureÂ S2</xref>.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>FigureÂ 3</label>
      <caption>
        <p>Block of Mevalonate Pathway Causes Cardiovascular Failure in Zebrafish Embryos by Reducing CoQ10 Synthesis</p>
        <p>(A) Wild-type (WT) embryos at 72 hpf treated from 54 hpf with statin (mevastatin) or DMSO. Statin treatments induce a <italic>bar</italic>-like phenotype which is characterized by hemorrhages (asterisk) and heart failure (arrowhead). Scale bar, 300Â Î¼m.</p>
        <p>(B) Three dimensional projections of trunk vessels at 72 hpf of DMSO and statin-treated zebrafish embryos. Statin treatments induce specific endothelial vessels regression and fragmentation in DA and Se (arrows). Scale bar, 100Â Î¼m.</p>
        <p>(C) Quantification of <italic>bar</italic>-like phenotype after statin treatments. MEV, mevastatin 500Â nM; SIM, simvastatin 500Â nM; MEN, mevinolin 500Â nM.</p>
        <p>(D and E) Levels of CoQ10 (D) and cholesterol (E) detected by HPLC-UV analyses in statin-treated embryos.</p>
        <p>(F and G) Bright-field (F) and fluorescent (G) images of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>ubiad1</italic><sup>+/+</sup> and <italic>ubiad1</italic><sup>+/â</sup> embryos at 65 hpf treated with mevastatin (2.5Â nM and 5Â nM) from 32 to 50 hpf. Treatment with a low dose of statin caused hemorrhages (asterisks) and altered heart morphology (arrowheads) in <italic>ubiad1</italic><sup>+/â</sup>, but not in <italic>ubiad1</italic><sup>+/+</sup> embryos. Although treatment with a low dose of statin did not induce specific alterations of the main vasculature, <italic>ubiad1</italic><sup>+/â</sup> embryos showed head vasculature, Se, and DA regression; scale bar, 300Â Î¼m.</p>
        <p>(H) Images of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>ubiad1</italic><sup>+/+</sup> and <italic>ubiad1</italic><sup>+/â</sup> embryos trunk vasculature show thinner and collapsed Se and DA morphology in statin-treated <italic>ubiad1</italic><sup>+/â</sup> but not in <italic>ubiad1</italic><sup>+/+</sup> embryos. Scale bar, 75Â Î¼m.</p>
        <p>(I) Penetrance of <italic>bar</italic>-like phenotype at 65 hpf after treatment with mevastatin. <italic>ubiad1</italic><sup>+/â</sup> embryos are significantly more sensitive to develop a <italic>bar</italic>-like phenotype than normal embryos (<italic>ubiad1</italic><sup>+/+</sup>).</p>
        <p>(J) CoQ10 supplemented embryos show less susceptibility to statin treatments in terms of developing a <italic>bar-</italic>like phenotype as indicated by histograms showing the percentage of statin-treated embryos having <italic>bar</italic>-like phenotype after exogenous CoQ10 delivery.</p>
        <p>(K) CoQ10 supplementation before statin treatment prevents cardiac edema (arrowhead) and brain hemorrhages (asterisk) in <italic>barolo</italic>. Images of vehicle- and CoQ10-injected embryos after statin treatment. Scale bar, 300Â Î¼m.</p>
        <p>(L) Histograms show oxidative stress in embryos after statin treatment with or without CoQ10.</p>
        <p>All data are means Â± SEM. <sup>âââ</sup>pÂ &lt; 0.001.</p>
        <p>See also <xref rid="figs3" ref-type="fig">FigureÂ S3</xref>.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="fig4">
      <label>FigureÂ 4</label>
      <caption>
        <p>UBIAD1 Is a Prenyltransferase Responsible for CoQ10 Synthesis in the Golgi Compartment</p>
        <p>(A and B) Confocal images of human ECs showing Ubiad1 colocalization with Golgi markers. (A) DNA (blue), human Ubiad1(red), and TGN46 (green). (B) DNA (blue), zebrafish Ubiad1-GFP (green), GM130 (red). Scale bar, 20Â Î¼m.</p>
        <p>(C) High-magnification confocal images of Golgi compartment showing colocalization between Ubiad1-GFP (green) and the Golgi marker Î³-adaptin (red). ScaleÂ bar, 10Â Î¼m.</p>
        <p>(D) Fluorescence images of human ECs transfected with Ubiad1-GFP and treated or not with brefeldin A (+BFA). After BFA treatment, Ubiad1 localization becomes diffuse throughout the cell. Scale bar, 10Â Î¼m.</p>
        <p>(E) Golgi compartment (Golgi, ER, and endosome fractions) and mitochondrial fractions from human ECs were analyzed by western blot with the following antibodies: Î³-Adaptin and Rab11, as marker for Golgi/ER/endosome fractions, HADHA (<italic>H</italic>ydroxyacyl-Co<italic>A D</italic>ehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA <italic>H</italic>ydratase [trifunctional protein], <italic>A</italic>lpha subunit) as marker for mitochondrial fractions.</p>
        <p>(F) Levels of <sup>13</sup>C<sub>6</sub>-isotope labeled CoQ10 (CoQ10-<sup>13</sup>C<sub>6</sub>) detected by HPLC-MS. Compared to control (siCTRL) the level of CoQ10-<sup>13</sup>C<sub>6</sub> present in cells silenced for UBIAD1 (siUBIAD1) is significantly reduced in Golgi compartment but not in mitochondria. Data are means Â± SD. <sup>ââ</sup>pÂ &lt; 0.01.</p>
        <p>See also <xref rid="figs4" ref-type="fig">FigureÂ S4</xref>.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="fig5">
      <label>FigureÂ 5</label>
      <caption>
        <p>SCCD UBIAD1 Variants Rescue <italic>barolo</italic> Mutants and Positively Regulate CoQ10 Synthesis</p>
        <p>(A) wild-type UBIAD1 (WT) or SCCD UBIAD1 isoforms (N102S; D112G) rescue <italic>bar</italic> mutants atÂ a significant extent.</p>
        <p>(B) Western blot analysis of protein extracts from HUAEC transfected with plasmids encoding for wild-type UBIAD1 (WT) or SCCD UBIAD1 isoforms (N102S; D112G).</p>
        <p>(CâE) HUAEC were transfected with plasmids encoding for wild-type UBIAD1 (WT) or SCCD UBIAD1 isoforms (N102S; D112G) and total lipid extracts were quantitated for CoQ10-<sup>13</sup>C<sub>6</sub> (C) and CoQ10 by HPLC-MS (D) and for cholesterol by HPLC-UV (E). Expression of all UBIAD1 proteins rises levels of CoQ10 as well as de novo synthetized CoQ10-<sup>13</sup>C but does not change cholesterol levels in human ECs.</p>
        <p>All data are means Â± SEM. <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="fig6">
      <label>FigureÂ 6</label>
      <caption>
        <p>Ubiad1 and Coq2 Play Different Functions during Development</p>
        <p>(A) Se integrity is affected in <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> embryos injected with <italic>ubiad1</italic> morpholino (<italic>ubiad1</italic> MO) but not in <italic>coq2</italic> morphants (<italic>coq2</italic> MO). Scale bar, 100Â Î¼m.</p>
        <p>(B) Oxidative stress levels in entire <italic>ubiad1</italic> morphants (<italic>ubiad1</italic> MO), <italic>coq2</italic> morphants (<italic>coq2</italic> MO), and relative control (ctrl MO).</p>
        <p>(C) CoQ10 levels detected by HPLC-MS are significantly lower in <italic>ubiad1</italic> morphants (<italic>ubiad1</italic> MO), <italic>coq2</italic> morphants (<italic>coq2</italic> MO), <italic>ubiad1</italic> and <italic>coq2</italic> double morphants (<italic>ubiad1+ coq2</italic> MO) than control morphants (ctrl MO).</p>
        <p>(D) Embryos from <italic>bar</italic> heterozygote intercrosses were injected with <italic>coq2</italic> mRNA and mitochondria-targeted CoQ10 analog called MitoQ (10Â Î¼M) or <italic>cherry</italic> mRNA and Decyl-TPP (10Â Î¼M) as respective controls. Phenotypes were scored at 72 hpf. <italic>bar</italic> phenotype is not caused by lack of mitochondria CoQ10.</p>
        <p>(E) Silencing of both CoQ10 biosynthetic enzymes (siUBIAD1 and siCOQ2) cause increase of total cellular ROS in ECs.</p>
        <p>(F) Levels of CoQ10 detected by HPLC-MS in totalÂ lipid extracts from HUAEC silenced for UBIAD1 (siUBIAD1), COQ2 (siCOQ2), or both (siUBIAD1+siCOQ2). UBIAD1 and COQ2 were silenced with 50 pmoles (black bars) or with 100 pmoles (gray bars). Levels of CoQ10 are significantly reduced in cells silenced for UBIAD1 or COQ2 expression.</p>
        <p>(G) Quantitative PCR analyses of UBIAD1 and COQ2 mRNA levels in HUAEC cells.</p>
        <p>(H) Quantification of loss of mitochondrial membrane potential (ÎÏ<sub>m</sub>) in HUAEC silenced for UBIAD1 (siUBIAD1) or COQ2 (siCOQ2).</p>
        <p>(I) Quantification of lipid peroxidation by MDA adducts levels in HUAEC silenced for UBIAD1 (siUBIAD1) or COQ2(siCOQ2).</p>
        <p>All data are means Â± SD. <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
        <p>See also <xref rid="figs5" ref-type="fig">FigureÂ S5</xref>.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="fig7">
      <label>FigureÂ 7</label>
      <caption>
        <p>NOS Activity in Cardiovascular Tissues Is Regulated by UBIAD1 and CoQ10</p>
        <p>(A) Knockdown of <italic>endothelial nitric oxide synthase 1 by</italic> morpholino (<italic>nos1</italic> MO) reduces the penetrance of <italic>bar</italic> phenotype at 72 hpf.</p>
        <p>(B) Knockdown of <italic>nos1</italic> rescue endothelial integrity defects of <italic>bar</italic> mutants. Images of Se of <italic>bar</italic> at 72 hpf injected with <italic>nos1</italic> morpholino (<italic>bar</italic>Â + <italic>nos1</italic>MO) or control morpholino (<italic>bar</italic>Â + <italic>ctrl</italic> MO) Scale bar, 50Â Î¼m.</p>
        <p>(C) Bright-field images (left) and fluorescent micrographs showing the trunk vasculature (right) of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> treated from 48 hpf with the specific eNOS inhibitor L-NAME (500Â Î¼M). Heart failure (arrowhead) and endothelial regression (arrows) were fully rescued by L-NAME treatment. Scale bar, 100Â Î¼m.</p>
        <p>(D) Penetrance of the <italic>bar</italic> phenotype at 65 hpf is significantly decreased by inhibition of eNOS activity with L-NAME treatment from 32 hpf.</p>
        <p>(E) Oxidative stress level in ECs derived from <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> mutant embryos is decreased by L-NAME treatment.</p>
        <p>(F) eNOS inhibition by L-NAME treatment significantly reduces ECs positive for S-nitroso-cysteine (SNO-Cys) in DA and PCV of <italic>bar</italic> embryos.</p>
        <p>(G) Silencing of eNOS (sieNOS) rescues oxidative stress induced by the lack of UBIAD1 (siUBIAD1). Silencing eNOS alone did not decrease ROS level in ECs.</p>
        <p>(H) Silencing of UBIAD1 gene (siUBIAD1) causes a significant decrease of eNOS activity in ECs evaluated as [<sup>3</sup>H]-L-citrulline.</p>
        <p>(I) Schematic representation of Ubiad1 molecular function in CoQ10 production and maintenance of nitrix oxide (NO) signaling. In wild-type cells, Ubiad1 localizes in the Golgi compartment and produces CoenzymeQ10 (CoQ10), an antioxidant molecule, important to counteract oxidative damage in particular in cellular membranes (cytosol and plasma membrane). In the Golgi compartment CoQ10 as an electron carrier might also play a fundamental role as a cofactor for eNOS activity by maintaining its âcoupledâ conformation and allowing normal NO production. On the other hand, lack of UBIAD1 and lowering of CoQ10, as occurs in the cardiovascular tissues of <italic>bar</italic> mutants, might âuncoupleâ eNOS causing loss of NO production and consequently reactive oxygen species overload leading to cellular oxidative damage (e.g., lipid peroxidation). Thereby, the â<italic>baroloâ</italic> phenotypes can be rescued by impairment of eNOS activity or expression.</p>
        <p>Data are means Â± SEM. <sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
        <p>See also <xref rid="figs6" ref-type="fig">FigureÂ S6</xref>.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <fig id="figs1">
      <label>FigureÂ S1</label>
      <caption>
        <p>Barolo Alleles Phenotypes Are Characterized by Oxidative Stress Leading to Progressive Cardiovascular Failure, Related to <xref rid="fig1" ref-type="fig">FigureÂ 1</xref></p>
        <p>(A) Wild-type siblings <sup>s847</sup> (sib) and <italic>barolo</italic><sup>s847</sup> (<italic>bar</italic>) mutant embryos at 72 hpf. Vascular hemorrhages (asterisk) and heart failure (arrowhead) are visible in <italic>bar</italic><sup>s847</sup> mutants. Scale bar, 300Â Î¼m.</p>
        <p>(B) Fluorescent micrographs of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> siblings (sib) and <italic>barolo</italic><sup>s847</sup> (<italic>bar</italic>) mutants at 72 hpf. <italic>bar</italic><sup>s847</sup> mutants show vascular integrity defects and regression both in brain and trunk vasculature (arrows). Endothelial cell regression is observed throughout the vascular network of <italic>bar</italic><sup>s847</sup> mutants at 72 hpf. The collapsed endocardium is also evident (arrowhead). Scale bar, 300Â Î¼m.</p>
        <p>(C) Fluorescent micrographs representing magnification of trunk vasculature of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> sib <sup>s847</sup> (sib) and <italic>barolo</italic><sup>s847</sup> (<italic>bar</italic>) mutants at 72 hpf. In <italic>bar</italic><sup>s847</sup> mutantâs endothelial cells are lost at the level of intersegmental vessels (Se), dorsal aorta (DA) and posterior cardinal vein (PCV) (arrows). Scale bar, 50Â Î¼m.</p>
        <p>(D) Histogram shows relative quantifications of oxidative stress in primary endothelial cells derived from <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> sib <sup>s847</sup> (sib) and <italic>bar</italic><sup>s847</sup> (<italic>bar</italic>) mutant at 65 hpf. ROS levels in endothelial cells of zebrafish embryos were measured by flow cytometric analyses using the specific CellROX probe on Kdrl:GFP+ cells. ROS level is significantly higher in <italic>bar</italic><sup>s847</sup> mutants than respective siblings. Results are shown as a mean of nÂ = 3 independent experiments. Data are means Â± SD.</p>
        <p>(E) Staining of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> sib<sup>s847</sup> (sib) and <italic>barolo</italic><sup>s847</sup> (<italic>bar</italic>) mutant embryos at 80 hpf for TUNEL (red) and DNA (blue). Left: confocal transverse sections of trunk vasculature at the level of the 10<sup>th</sup> somite; right: histograms report numbers of dorsal aorta and posterior cardinal vein cells positive for TUNEL staining. Data are means Â± SD; <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001. TUNEL-positive cells were also present in pronephric ducts of <italic>bar</italic> mutants. Scale bars, 100Â Î¼m.</p>
        <p>(F) Validation of inÂ vivo <italic>ubiad1</italic> knockdown by morpholino injection. Left: schematic diagram shows the molecular mechanism of <italic>ubiad1</italic>splice-morpholino (<italic>ubiad1</italic> MO; dashed line). <italic>ubiad1</italic> MO targeting the splicing site between exon1 (EX1) and intron1 blocks <italic>ubiad1</italic> pre-mRNA maturation and leads to <italic>ubiad1</italic> non-coding mRNA. Molecular mechanism of control non-targeting morpholino (<italic>ctrl</italic> MO) is also indicated. Primers used for RT-PCR validation are localized on exons 1 and 2 (EX1-EX2; black arrows). Right: RT-PCR analysis was performed on cDNA from zebrafish embryos 72Â hr post microinjection. Amplification of 339Â bp is possible only for cDNA from ctrl-injected embryos, whereas no amplification is expected from <italic>ubiad1</italic>MO-injected embryos. Compared to ctrl MO, <italic>ubiad1</italic> MO show reduced 339Â bp PCR products.</p>
        <p>Representative bright-field images of <italic>ubiad1</italic> morphants (<italic>ubiad1</italic> MO) and relative control (<italic>ctrl</italic> MO) at 48 hpf (G) and 72 hpf (H). <italic>ubiad1</italic> morphants such as <italic>bar</italic> mutants are characterized by brain hemorrhages (asterisk) and stringy heart morphology (arrowhead). Scale bar, 100Â Î¼m.</p>
        <p>(I) Fluorescent micrographs of trunk vasculature (between 14<sup>th</sup> and 18<sup>th</sup> somites) of <italic>Tg (kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>ubiad1</italic> morphants (<italic>ubiad1</italic> MO) and control (<italic>ctrl</italic> MO) injected embryos at 72 hpf. Knockdown of <italic>ubiad1</italic> led to loss of intersegmental vessels integrity (arrows) as observed in <italic>bar</italic> mutants. Scale bar, 75Â Î¼m.</p>
        <p>(J) RT-PCR analyses for <italic>ubiad1</italic> mRNA expression and <italic>ef1Î±</italic> (as control) on cDNA from wild-type embryos at different developmental stages. Samples are from 4-cell stage to 96 hpf stage.</p>
        <p>(K) Whole-mount ISH analyses of wild-type embryo at 24 hpf show <italic>ubiad1</italic> mRNA expression throughout the embryo. Scale bar, 250Â Î¼m.</p>
        <p>(L) Magnification on heart of whole-mount ISH analyses of wild-type embryo at 48 hpf. Specific expression of <italic>ubiad1</italic> mRNA can be detected in the developing heart. A, atrium; V, ventricle. Scale bar, 50Â Î¼m.</p>
        <p>(M) Cell transplantation experiments in <italic>barolo</italic> mutant embryos. Confocal fluorescent image shows chimeric vessels made of endothelial cells from <italic>Tg(fli:GFP)</italic><sup><italic>y1</italic></sup><italic>bar</italic><sup>t31131</sup> mutant embryos (donor) that have been transplanted at pre-dome stage into <italic>Tg(kdrl: mCherry)</italic><sup><italic>uto2</italic></sup> wild-type (<italic>wt</italic>) embryos (acceptor) and visualized at 48 hpf. Transplanted mutant endothelial cells (green fluorescence) show retracting and collapsed morphology (arrows), also at the level of intersegmental vessel (Se) and dorsal aorta (DA) suggesting <italic>ubiad1</italic> acts cell autonomously. Left: mCherry channel corresponding to <italic>Tg(kdrl: mCherry)</italic><sup><italic>uto2</italic></sup> wild-type cells. Middle: GFP channel corresponding to <italic>Tg(fli:GFP)</italic><sup><italic>y1</italic></sup><italic>bar</italic><sup>t31131</sup> mutant endothelial cells. Right: Merge image of mCherry and GFP channels. Se, intersomitic vessels; DA, dorsal aorta; PCV, posterior cardinal vein. Scale bar, 20Â Î¼m.</p>
        <p>(N) Bright field (left) and corresponding fluorescent micrographs (right) of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> and <italic>Tg</italic> [<italic>(kdrl-Ubiad1-2A-mCherry)</italic><sup><italic>uto35</italic></sup><italic>; (kdrl:GFP)</italic><sup><italic>s843</italic></sup> ] wild-type embryos injected with <italic>ubiad1</italic> splice-morpholino (<italic>ubiad1</italic> MO). After morpholino injection <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> embryos show characteristic <italic>barolo</italic> phenotype (upper). On the contrary, after <italic>ubiad1</italic> morpholino injection <italic>Tg [(kdrl-Ubiad1-2A-mCherry)</italic><sup><italic>uto35</italic></sup><italic>; (kdrl:GFP)</italic><sup><italic>s843</italic></sup> ] show wild-type phenotype (lower). Scale bar, 400Â Î¼m.</p>
        <p>(O) Magnification of trunk vasculature of embryos showed in (N). Green fluorescence shows endothelial cells. Red fluorescence, which is exclusive of <italic>uto</italic><sup><italic>35</italic></sup> line, indicates expression of exogenous Ubiad1 in endothelial cells (lower right). Injection of <italic>ubiad1</italic> morpholino in <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> induce <italic>bar</italic> phenotype characterized by intersegmental vessels (Se) disintegration and collapsed dorsal aorta (DA) (upper left; arrows). Injection of <italic>ubiad1</italic> morpholino in <italic>Tg [(kdrl-Ubiad1-2A-mCherry)</italic><sup><italic>uto35</italic></sup><italic>;(kdrl:GFP)</italic><sup><italic>s843</italic></sup> ] do not exert any vascular phenotype (lower left; arrowheads) indicating that endothelial-specific expression of Ubiad1 is sufficient to prevent barolo cardiovascular phenotype. All together these data support that Ubiad1 acts cell autonomously in vascular cells. Scale bar, 150Â Î¼m.</p>
        <p>(P) Validation of <italic>ubiad1</italic> knockdown by morpholino injection, related to embryos in (N and O). RT-PCR analysis was performed on cDNA from zebrafish embryos at 72 hpf. Amplification of 339bp is possible only for cDNA from ctrl MO-injected embryos (ctrl MO), whereas no amplification is expected from <italic>ubiad1</italic>MO-injected embryos (<italic>ubiad1</italic> MO). Compared to ctrl MO, <italic>ubiad1</italic> MO show reduced 339bp PCR products in <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> (s843) as well as in <italic>Tg [(kdrl-Ubiad1-2A-mCherry)</italic><sup><italic>uto35</italic></sup><italic>; (kdrl:GFP)</italic><sup><italic>s843</italic></sup> ] (s843:uto35) morphants. RT-PCR strategy is showed in (F).</p>
        <p>(Q) Chronological documentation of <italic>barolo</italic> phenotypes onset. <italic>bar</italic><sup><italic>t31131</italic></sup> mutant embryos phenotype starts with an increase of oxidative stress (detectable from 32 hpf until 60 hpf) that causes a progressive cardiovascular breakdown characterized by vessels regression and fragmentation (starting from 40 hpf), hemorrhages (from 48 hpf) and heart failure (from 60 hpf). <italic>barolo</italic> cardiovascular degeneration ends up with heart and vascular cells apoptosis that become evident at molecular levels starting from 60 hpf. Definitive signs of apoptosis can be scored at 72 hpf.</p>
        <p><italic>bar</italic><sup>s847</sup> shows the same progressive cardiovascular failure features of as <italic>bar</italic><sup>t3113</sup>, but delayed of 12Â hr in the same experimental conditions. Both <italic>barolo</italic> alleles are not able to survive over 96 hpf.</p>
      </caption>
      <graphic xlink:href="figs1"/>
    </fig>
    <fig id="figs2">
      <label>FigureÂ S2</label>
      <caption>
        <p>UBIAD1 Regulates CoQ10 but Not Cholesterol or Vitamin K2 Levels in Zebrafish Embryos and Human Endothelial Cells, Related to <xref rid="fig2" ref-type="fig">FigureÂ 2</xref></p>
        <p>(A) Histograms show levels of cholesterol detected by HPLC-UV analysis in bar<sup>t31131</sup> and respective siblings (sib) or ubiad1 morphants and relative controls (<italic>ctrl</italic> MO). The level of total cholesterol is not affected among all conditions. The results are shown as a mean of nÂ = 6 independent experiments for each condition. Error bars indicate SD of measurements.</p>
        <p>(B) Histograms show levels of CoQ10 determined by HPLC-UV analysis during zebrafish development starting from 24 hpf to 72 hpf embryos. Whole embryos (black) and deyolk embryos (gray) lipid extracts were subjected to chemical quantitative analyses. Equal amount of CoQ10 is detected in both compartments suggesting CoQ10 is produced entirely by zygotic tissues. Each sample is a pool of 25 zebrafish embryos at the same developmental stage. Error bars indicate SD of measurements.</p>
        <p>(C) Histograms show levels of cholesterol determined by HPLC-UV analysis during zebrafish development starting from 24 hpf to 72 hpf embryos. Whole embryos (black) and deyolk embryos (gray) lipid extracts were subjected to chemical quantitative analyses. Cholesterol is higher in extracts containing the whole embryo suggesting a large amount of cholesterol is present in the yolk sac. Each sample is a pool of 25 zebrafish embryos at the same developmental stage. Error bars indicate SD of measurements.</p>
        <p>Analysis of lipid extracts from zebrafish embryos for Vitamin K levels.</p>
        <p>(D) Mass spectrum corresponding to the peak in chromatogram (E) at retention time 4.0Â min and corresponding to Vitamin K2 standard. Vitamin K2 is detected as 445 m/z [molecule-H<sup>+</sup>].</p>
        <p>(E) SIM chromatogram of a 1Â mM standard mix of Vitamin K2. Select Ion Monitoring (SIM) (m/zÂ = 445) allows us to have a maximum sensibility toward Vitamin K2. Peak corresponds to Vitamin K2 standard. Vitamin K2 retention time is 4.0Â min.</p>
        <p>(F) TIC chromatogram of 1Â mM standard mix shown in (E). The arrow shows the peak of Vitamin K2.</p>
        <p>(G) TIC chromatogram of lipid extract from <italic>bar</italic><sup><italic>t31131</italic></sup>sibling. No Vitamin K2 peak is evident. This sample was also recorded for SIM-HPLC-MS chromatograms too, but there is no variation to control (data not shown).</p>
        <p>(H) TIC chromatogram of lipid extract from <italic>bar</italic><sup><italic>t31131</italic></sup> mutant embryos. No Vitamin K2 peak is evident. This sample was also recorded for SIM-HPLC-MS chromatograms, but there is no variation to control (data not shown).</p>
        <p>(I) TIC chromatogram of lipid extract from UBIAD1overespression human primary endothelial cells. No Vitamin K2 peak is evident. This sample was also recorded for SIM-HPLC-MS chromatograms too, but there is no variation to control (data not shown).</p>
        <p>(J) Full mass chromatogram of human primary endothelial cells (HUAEC) lipid extracts incubated with 4-hydroxy-benzoic acid-<sup>13</sup>C<sub>6</sub> for 48Â hr. Channel I: CoQ10 (m/zÂ = 885.7, retention time: 10.46); Channel II: CoQ9 (m/zÂ = 8117.6, retention time: 7.78); Channel III: CoQ10-<sup>13</sup>C<sub>6</sub> (m/zÂ = 891.7, retention time: 10.46Â min).</p>
        <p>(K) Mass spectrum chromatogram of human primary endothelial cells (HUAEC) lipid extracts incubated with hydroxyl-4-benzoic acid-<sup>13</sup>C<sub>6</sub> for 48h. Chromatogram corresponds to the MS picks of CoQ10 and <sup>13</sup>C<sub>6</sub>-labeled CoQ10 (CoQ10-<sup>13</sup>C<sub>6</sub>). CoQ10 is detected as m/z 885.6804 [molecule-Na<sup>+</sup>] and CoQ10-<sup>13</sup>C<sub>6</sub> is detected as m/z 891.7011 [molecule-Na<sup>+</sup>], respectively. Endothelial cells metabolize 4-hydroxy-benzoic acid-<sup>13</sup>C<sub>6</sub> into CoQ10-<sup>13</sup>C<sub>6</sub>.</p>
      </caption>
      <graphic xlink:href="figs2"/>
    </fig>
    <fig id="figs3">
      <label>FigureÂ S3</label>
      <caption>
        <p>Statin-Dependent <italic>barolo</italic> Phenotype Is Caused by CoQ10, but Not Cholesterol or Protein Prenylation, Deficiency, Related to <xref rid="fig3" ref-type="fig">FigureÂ 3</xref></p>
        <p>(A) Schematic representation of mevalonate biosynthetic pathway and inhibitors used in this work to block final products of this metabolic pathway: CoQ10, prenylated protein and cholesterol. Mevalonate-derived farnesyl-pyrophasphates (Farnesyl PP: FPP) is the key intermediate for protein isoprenylation, cholesterol and CoQ10 biosynthesis. Specific inhibitors used in this work are indicated in blue and are: statins (HMG-CoA reductase inhibitor), FTI (Farnesyl Tranferase Inhibitor), GGTI (Geranyl-Geranyl Transferase Inhibitor) and SQI (Squalene synthase Inhibitor). Statins were used to block mevalonate pathway and FPP synthesis. FTI and GGTI were used to specifically block protein isoprenylation, while SQI was used to block cholesterol synthesis.</p>
        <p><italic>(B) Histograms show the percentage of embryos treated with SQI, FTI-277 and GGTI-2133 inhibitors</italic> and displaying wild-type morphology. Inhibition of protein isoprenilation by treatment with FTI and GTI or inhibition of de novo biosynthesis of cholesterol by SQI treatment does not phenocopy <italic>bar</italic> mutants or perturb embryos development. FTI, farnesyltransferase inhibitor, GGTI, geranylgeranyl transferase inhibitor, SQI, squalene synthase inhibitor.</p>
        <p><italic>(C) Histograms show HPLC-MS quantifications of CoQ10 from lipid extracts of wild-type zebrafish embryos treated with the</italic> SANOMIT nanoparticles CoQ10 liquid (COQ10 <sup>F3</sup>; 6.95Â mM) and relative control. Compared to control sample, SANOMIT treated embryos show higher amount of CoQ10 indicating that CoQ10 is delivered and correctly adsorbed by developing embryos.</p>
        <p>All data are means Â± SEM. <sup>ââ</sup>pÂ &lt; 0.01.</p>
      </caption>
      <graphic xlink:href="figs3"/>
    </fig>
    <fig id="figs4">
      <label>FigureÂ S4</label>
      <caption>
        <p>UBIAD1 Is Localized in the Golgi Compartment, Related to <xref rid="fig4" ref-type="fig">FigureÂ 4</xref></p>
        <p>Confocal images of human primary endothelial cells (HUAEC) transfected with control siRNA (siCTRL) and UBIAD1 siRNA (siUBIAD1) and stained for DNA (blue) and UBIAD1 (red). Compared to control, siUBIAD1-silenced cells lose the Golgi compartment fluorescence signal conforming the specificity of the 9D4 antibody and the Golgi-localization of UBIAD1. Scale bar, 20Â Î¼m.</p>
      </caption>
      <graphic xlink:href="figs4"/>
    </fig>
    <fig id="figs5">
      <label>FigureÂ S5</label>
      <caption>
        <p>UBIAD1 Functions Differently from Mitochondrial COQ2, Related to <xref rid="fig6" ref-type="fig">FigureÂ 6</xref></p>
        <p>(A) Validation of inÂ vivo <italic>coq2</italic> knockdown by morpholino injection. Left: schematic diagram shows the molecular mechanism of <italic>coq2</italic> splice- morpholino (<italic>coq2</italic> MO; dashed line). <italic>coq2</italic> MO targeting the splicing site between exon2 (EX2) and intron2 (IN2) blocks <italic>coq2</italic> pre-mRNA maturation and leads to <italic>coq2</italic> non-coding mRNA. Molecular mechanism of control non-targeting morpholino (ctrl MO) is also indicated. Primers used for RT-PCR validation are localized on exons 1 and exon 8 (EX1, EX8; black arrows). RT-PCR analysis was performed on cDNA from zebrafish embryos at 48h and 72Â hr post microinjection. Amplification of 1129bp is possible only for cDNA from ctrl MO-injected embryos, whereas no amplification is expected from <italic>coq2</italic> MO-injected embryos. Compared to control morphants, <italic>coq2</italic> MO show reduced PCR products.</p>
        <p>Representative bright field pictures of <italic>coq2</italic> morphants (<italic>coq2</italic> MO) and controls (<italic>ctrl</italic> MO) at 48 hpf (B) and 72 hpf (C). At 48 hpf <italic>coq2</italic> MO show hindbrain edema (arrow), and abnormal yolk sac morphology. Scale bar, 500Â Î¼m. At 72 hpf <italic>coq2</italic> morphants show severe brain edema (arrow) and severe development delayed. These are typical features of reduced energy metabolism possibly due to primary CoQ10 deficiency. Scale bar, 300Â Î¼m.</p>
        <p>(D) Histograms show levels of endogenous CoQ9 detected by HPLC-MS analyses in <italic>ubiad1</italic> morphants (<italic>ubiad1</italic> MO), <italic>coq2</italic> morphants (<italic>coq2</italic> MO), double morphants (<italic>ubiad1+ coq2</italic> MO). Compared to control (<italic>ctrl</italic> MO), the CoQ9 levels are significantly lower in <italic>ubiad1</italic> morphants. <italic>coq2</italic> morphants show a reduced decreased in CoQ9 levels compared to <italic>ubiad</italic> morphants. Such difference is under investigation. Results are shown as a mean of nÂ = 3 independent experiments for each condition.</p>
        <p>(E) Mitochondria-targeted CoQ10 (MitoQ) efficiently rescue <italic>coq2</italic> morphants. Histogram shows the percentage of embryos showing the <italic>coq2</italic> morpholino phenotype when injected with mitochondria-targeted CoQ10 (MitoQ; 10Â Î¼M) or its respective control (D-TPP). Supplementation of MitoQ but not of D-TPP clearly rescues the absence of <italic>coq2</italic> in zebrafish embryos. Results are shown as a mean of nÂ = 3 independent experiments for each condition.</p>
        <p>(F) Histograms show levels of <sup>13</sup>C<sub>6</sub>-labeled CoQ10 (CoQ10-<sup>13</sup>C<sub>6</sub>) detected by HPLC-MS in total lipid extracts from human primary endothelial cells (HUAEC) silenced for UBIAD1 (siUBIAD1), COQ2 (siCOQ2) or both (siUBIAD1+siCOQ2). UBIAD1 and COQ2 were silenced with 50 pmoles (black bars) or with 100 pmoles (gray bars) of respective siRNA. Compared to relative control (siCTRL), the levels of CoQ10-<sup>13</sup>C<sub>6</sub> are significantly reduced in cells silenced for UBIAD1 or COQ2 expression. The combination of the two siRNA further decrease CoQ10 levels. Results are shown as a mean of nÂ = 3 independent experiments for each condition.</p>
        <p>(G) Confocal images of human primary endothelial cells (HUAEC) transfected with siRNA for UBIAD1 (siUBIAD1), COQ2 (siCOQ2) or control (siCTRL) and stained for mitochondria (red) and DNA (blue). Regular reticular mitochondrial morphology is detected in cells treated with siUBIAD1 and siCTRL. On the contrary, cells treated with siCOQ2 show less and fragmented mitochondria. Scale bar, 10Â Î¼m.</p>
        <p>(H) Magnification of the area outlined in (G). siCOQ2-treated cells show few and collapsed mitochondria (arrowhead). In contrast normal reticular mitochondria morphology is evident in siUBIAD1- and siCTRL-treated cells. Scale bar, 0.5Â Î¼m.</p>
        <p>(I) Histograms show the loss of mitochondria membrane potential (ÎÏ<sub>m</sub>) of human EC silenced for COQ2 after treatment with the mitochondria-targeted CoQ10 (MitoQ) efficiently rescue <italic>coq2</italic> morphants. MitoQ (10nM) but not D-TPP (10nM) supplementation efficiently rescues loss of mitochondrial membrane potential of siCOQ2 ECs. These results indicate that mitochondrial damage in siCOQ2 cells is due to loss of mitochondrial CoQ10. Results are shown as a mean of nÂ = 3 independent experiments for each condition.</p>
        <p>All data are means Â± SD, <sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="figs5"/>
    </fig>
    <fig id="figs6">
      <label>FigureÂ S6</label>
      <caption>
        <p>UBIAD1 Regulates a Blood Flow-Dependent NO Signaling and NO-dependent Oxidative Stress, Related to <xref rid="fig7" ref-type="fig">FigureÂ 7</xref></p>
        <p>(A) Embryos from <italic>bar</italic><sup><italic>t31131</italic></sup> heterozygote intercrosses were injected at one-cell stage with <italic>tnnt2</italic> morpholino (<italic>tnnt2</italic> MO) or <italic>Kruppel-like factor 2a</italic> morpholino (<italic>klf2a</italic> MO) or control morpholino (<italic>ctrl</italic> MO). Histogram shows the percentage of larvae showing the <italic>bar</italic> mutant phenotype at 72 hpf after injection. Compared to control, impairment of the blood flow-Klf2a pathway by morpholino injection significantly delayed the penetrance of the <italic>bar</italic> phenotype, evaluated as trunk vessels disintegration. Results are shown as a mean of nÂ = 2 independent experiments for each condition.</p>
        <p>(B) Fluorescent micrographs of DLAV and Se of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic> mutants at 72 hpf after injection of control morpholino (ctrl MO), <italic>tnnt2</italic> morpholino (<italic>tnnt2</italic> MO), <italic>klf2a</italic> morpholino (<italic>klf2a</italic> MO). Knockdown of <italic>tnnt2</italic> and <italic>klf2a</italic> delayed Se and DLAV disintegration in <italic>bar</italic> mutants. Se, intersegmental vessels; DLAV: dorsal longitudinal anastomotic vessel. Scale bar, 75Â Î¼m.</p>
        <p>(C) Histograms show oxidative stress levels in endothelial cells (EC) derived from <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic><sup>t31131</sup> after <italic>klf2a</italic> morpholino injection. <italic>barolo</italic> mutants were injected with control morpholino (ctrl MO) or <italic>klf2a</italic> morpholino (<italic>klf2a</italic> MO). Compared to control-injected embryos, <italic>klf2a</italic> MO-injected <italic>barolo</italic> (<italic>bar</italic>) mutants show reduced EC oxidative stress levels. Results are shown as a mean of nÂ = 2 independent experiments for each condition.</p>
        <p>(D) Histograms show oxidative stress levels in endothelial cells derived from <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup> and <italic>bar</italic><sup>t31131</sup> (<italic>bar</italic>) mutant at 65 hpf after treatment with the NO donor, S-nitroso-N-acetyl-DL-penicillamine (SNAP) or DMSO as control. ROS levels in endothelial cells of zebrafish embryos were measured by flow cytometric analyses using the specific CellROX probe on Kdrl:GFP+ cells. NO overload in <italic>barolo</italic> cardiovascular tissues significantly enhances oxidative stress level. Results are shown as a mean of nÂ = 2 independent experiments for each condition.</p>
        <p>(E) Representative confocal 3D projections of trunk vasculature between 10<sup>th</sup> and 18<sup>th</sup> somites of <italic>Tg(Kdrl:mCherry)</italic><sup><italic>uto2</italic></sup><italic>barolo</italic><sup>s847</sup>(<italic>bar</italic>) mutant at 65 hpf. Embryos were treated from 48 hpf with the NO inhibitor, N- Nitro-L-arginine methyl ester hydrochloride (L-NAME; 500Â Î¼M) or NO donor, S-nitroso-N-acetyl-DL-penicillamine (SNAP; 100Â Î¼M) or equivalent volume of DMSO as control.</p>
        <p>Compared to DMSO-treated embryos, L-NAME treatment efficiently prevents cardiovascular failure as indicated by intact dorsal aorta (DA), posterior cardinal vein (PCV) and intersegmental vessels integrity (Se) (arrows). On the other hand, SNAP treatment accelerates oxidative stress and cardiovascular failure in bar mutant embryos. Scale bar, 150Â Î¼M.</p>
        <p>(F) Confocal transverse sections of <italic>Tg(kdrl:GFP)</italic><sup><italic>s843</italic></sup><italic>bar</italic><sup>t31131</sup> trunk vasculature at the level of 10<sup>th</sup> somite and stained for S-nitroso-cysteine, a biomarker of oxidative damage at 65 hpf. Confocal acquisitions are showed as single channel images and relative merged image: DNA (DAPI, blue), S-nitroso-cysteine (SNO-Cys, red), endothelium (Kdrl; green). <italic>bar</italic><sup>t31131</sup> were previously treated with the NO inhibitor, L-NAME (500Â Î¼M) or NO donor, SNAP (100Â Î¼M) or DMSO as relative control. Oxidative stress-positive cells are detectable in dorsal aorta (DA) and posterior cardinal vein (PCV) in <italic>bar</italic><sup><italic>t31131</italic></sup> (arrows) and SNAP-treated <italic>bar</italic> embryos. L-NAME treatment blocks oxidative stress in cardiovascular cells but not in pronephros suggesting a eNOS-dependent mechanism in oxidative stress caused by the loss of Ubiad1. DA, dorsal aorta; PCV posterior cardinal vein. Scale bar, 20Â Î¼m.</p>
        <p>(G) Histograms show numbers of endothelial cells in dorsal aorta (DA) and posterior caudal vein (PCV) positive for S-nitroso-cysteine (SNO-Cys) in <italic>bar</italic> mutant embryos treated with DMSO or the NO donor, SNAP (100Â Î¼M). Comparative confocal 3D projections were analyzed for SNO-Cys-positive endothelial cells in dorsal aorta and posterior cardinal vein. Results are shown as a mean of nÂ = 3 independent experiments for each condition.</p>
        <p>(H) Histograms show NOS activity in protein extracts from barolo mutants (<italic>bar</italic>) and siblings (sib) at 72 hpf. Evaluation of NOS activity was based on conversion of [<sup>3</sup>H]-L-arginine to [<sup>3</sup>H]-L-citrulline. <italic>bar</italic><sup><italic>t31131</italic></sup> and <italic>bar</italic><sup><italic>s843</italic></sup> mutants show significant reduction in NOS activity compared to controls. These results indicate that loss of Ubiad1 impairs NOS enzymatic activity and therefore NO production. Results are shown as a mean of nÂ = 2 independent experiments for each condition.</p>
        <p>(I) Representative micrographs of <italic>bar</italic> mutant embryos (<italic>bar</italic>) and siblings (sib) stained for nitric oxide (NO) with the green fluorescent probe 4,5 Diaminofluorescein Diacetate (DAF-2DA) at 72 hpf. NO production in the notochord (NC; arrows) and bulbus arteriousus (BuA; arrowheads) are evident in sibling but not in <italic>bar</italic> mutants. Scale bar, 300Â Î¼m. BuA, bulbus arteriosus; NC, notochord.All data are means Â± SEM; <sup>â</sup>pÂ &lt; 0.05, <sup>ââ</sup>pÂ &lt; 0.01, <sup>âââ</sup>pÂ &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="figs6"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>